Cancer Diagnosis & Pathology Research Group

Drey SB, Upstill-Goddard R, Paulus-Hock V, Paris C, Lampraki E-M, Dray E, Serrels B, Cligiuri G, Rebus S, Plenker D, Galluzzo Z, Brunton H, Cunningham R, Tesson M, Nourse C, Bailey U-M, Jones M, Moran-Jones K, Wright DW, Duthie F, Oien K, Evers L, McKay CJ, McGregor GA, Gulati A, Brough R, Bajrami I, Pettitt S, Dziubinski ML, Candido J, Balkwill F, Barry ST, B, Grützmann R, Rahib L, Glasgow Precision Oncology Laboratory, Australian Pancreatic Cancer Genome Initiative, Johns A, Pajic M, Froeling FEM, Beer P, Musgrove EA, Peterson GM, Ashworth A, Frame MC, Crawford HC, Simeone DM, Lord C, Mukhopadhyay D, Pilarsky C, Tuveson DA, Cooke SL, Jamieson NB, Morton JP, Sansom OJ, Bailey PJ, Biankin AV, Chang DK  Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer Gastroenterology 2021; 160:362-377

McEvoy CR, Holliday H, Thio N, Mitchell C, Choong D, Yellapu B, Leong HS, Xu H, Lade S, Browning J, Takano E, Byrne A, Gill AJ, Duong C, Li J, Fellowes A, Fox S, Swarbrick A, Prall O A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumors Laboratory Investigation 2021;101:26–37

Gill AJ Why did they change that? Practical implications of the evolving classification of neuroendocrine tumours of the gastrointestinal tract Histopathology 2021; 78:162-170

Janseen BV, Tutucu F, van Roessel S, Adsay V, Basturk O, Campbell F, Doglioni C, Esposito I, Feakins R, Fukushima N, Gill AJ, Hruban RH, Kaplan J, Koerkamp BG, Hong S-M, Krasinkas A, Luchini C, Offerhaus H, Sarasqueta AF, Shi C, Singhi A, Stoop TF, Soer EC, Thompson E, van Tienhover G, Velthuysen M-L F, Wilmink JW, Besselink MG, Brosens LAA, Wang H, Verbeke CS, Verheij J for the International Study Group of Pancreatic Pathologists (ISGPP) Amsterdam International Consensus Meeting: Tumor Response Scoring in the Pathology Assessment of Resected Pancreatic Cancer after Neoadjuvant Therapy Modern Pathology  2021;34:4–12

Vargas AC, Gray L-A, White CL, Maclean FM, Grimison P, Ardakani NM, Bonar F, Algar EM, Cheah AL, Russell P, Mahara A, Gill AJ Genome-wide methylation profiling of selected matched soft tissue sarcomas identifies methylation changes in metastatic/recurrent disease Scientific Reports 2021;11:667

Huang Y, Domodaran Prabha R, Chua TC, Arena J, Koetecha K, Mittal A, Gill AJ, Samra JS Yeqian Huang, Ramesh Damodaran Prabha, Terence C Chua, Jennifer Arena, Krishna Kotecha, Anubhav Mittal, Anthony J Gill, Jaswinder S Samra

Safety and Efficacy of Pancreaticoduodenectomy in Octogenarians Frontiers in Surgery 2021;8:617286

Steffen P, Li J, Chandra J, Ahadi MS, Gill AJ, Engel AF, Molloy MP Molecular features of lymph node metastasis in T1/2 colorectal cancer from formalin-fixed paraffin embedded archival specimens J Proteome Res Accepted 2021;8:617286

Lakis V, Lawlor RT, Newell F, Patch AM, Mafficini A, Sadanandam A, Koufariotis LT, Johnston RL, Leonard C, Wood S, Rusev B, Corbo V, Luchini C, Cingarlini S, Landoni L, Salvia R, Milella M, Chang D, Bailey P, Jamieson NB, Duthie F, Gingras MC, Muzny DM, Wheeler DA, Gibbs RA, Milione M; APGI; ARC-Net, Pederzoli P, Samra JS, Gill AJ, Johns AL, Pearson JV, Biankin AV, Grimmond SM, Waddell N, Nones K, Scarpa A DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association Commun Biol. 2021;4(1):155

Sahni S, Pandya AR, Hadden WJ, Nahm C, Maloney S, Cook V, Toft JA, Wilkinson-White L, Gill AJ, Samra JS, Dona A and Mittal A. A Unique Urinary Metabolomic Signature for the Detection of Pancreatic Ductal Adenocarcinoma International J Cancer  2021;148(6):1508-1518

Cottle L, Gan WH, Gilroy I, Samra JS, Gill AJ, Loudovaris T, Thomas HE, Hawthore WJ, Kebede MA, Thorn P Structural and functional polarisation of human pancreatic beta cells in healthy islets and islets from type 2 diabetic patients Diabetologia 2021;64:618-629.

Wurth R, Jha A, Kamilaris C, Gill AJ, Poplawski N, Xekouki P, Quezado MM, Pacak K, Stratakis C, Hannah-Shmouni F A Case of Carney Triad complicated by Renal Cell Carcinoma and a Germline SDHA Pathogenic Variant Endocrinology, Diabetes and Metabolism Case Reports March 2021;DOI: 10.1530/EDM-0170

Horton RK, Ahadi M, Gill AJ, Wu T-T, Said, S, Chen ZE, Bakhswin A, Nichols M, Goldblum JR, Graham RP SMARCA4/SMARCA2-Deficient Carcinoma of the Esophagus and Gastroesophageal Junction Am J Surg Pathol 2021; 45(3):414-420

Chou A, Ahadi M, Arena J, Sioson L, Sheen A, Fuchs TL, Pavlakis N, Clarke S, Kneebone A, Hruby G, Sahni S, Mittal A, Samra J, Gill AJ A critical assessment of post neoadjuvant pancreatic cancer regression grading schemes with a proposal for a novel approach American Journal of Surgical Pathology 2021;45:394-404

Seabrook A, Harris JE, Velosa S, Kim E, McInerney-Leo AM, Dwight T, Hocking JI, Hocking NG, Kirk J, Leo P, Love A, Luxford C, Marshall M, Mete O, Pennisi D, Brown MA, Gill AJ, Hocking GI, Clifton-Bligh RJ, Duncan EI Multiple Endocrine Tumours associated with germline MAX mutations: Multiple Endocrine Neoplasia Type 5? Journal of Clinical Endocrinology and Metabolism 2021;106:1163-1182

Liu J, Itchins M, Nagrial A, Cooper WA, de Silva M, Barnet M, varikatt W, Sivasubramaniamk V, Davis A, Gill AJ, Blinman P, Lee K, Hui R, Gao B, Pavlakis N, Clarke S, Lee J, Boyer M, Kao S Relationship between PD-L1 expression and outcome in EGFR-mutant lung cancer patients treated with EGFR tyrosine kinase inhibitors Lung Cancer 2021;155:28-33

Giordano TJ, Berney D, de Krijger RR, Erickson L, Fassnacht M, Mete O, Papathomas T, Papotti M, Sasano H, Thompson LDR, Volante M, Gill AJ Data set for reporting of carcinoma of the adrenal cortex: Explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting (ICCR) Human Pathology 2021;110:50-61

Ghossein R, Barlett JA, Bullock M, Johnson SJ, Kakudo K, Lam AK, Moonim MT, Poller DN, Tallini G, Tuttle M, Xu B, Gill AJ Data set for reporting carcinoma of the thyroid: Recommendations from the International Collaboration on Cancer Reporting (ICCR) Human Pathology 2021;110:62-72

Williams MD, DeLellis RA, Ericskon LA, Gupta R, Johnson SJ, Kameyama K, Natu S, Ng T, Perren A, Perrier ND, Seethala RR, Gill AJ Pathology Data set for reporting Parathyroid Carcinoma & Atypical Parathyroid Neoplasm: recommendations from the International Collaboration on Cancer Reporting (ICCR) Human Pathology 2021; 110:73-82

Thompson LDR, Gill AJ, Asa SL, Clifton-Bligh RJ, de Krijger RR, Papathomas TG, Sadow PM, Tischler AS Dataset for the reporting of phaeochromocytoma and paraganglioma: Explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting (ICCR) Human Pathology 2021; 110:83-97

Washington MK, Goldberg RM, Chang GJ, Limburg P, Lam AK, Salto-Tellez M, Arends MJ, Nagtegaal ID, Klimstra DS, Rugge M, Schirmacher P, Lazar AJ, Odze RD, Carneiro F, Fukayama M, Cree IA; WHO Classification of Tumours Editorial Board Diagnosis of digestive system tumours Diagnosis of digestive system tumours Int J Cancer. 2021;148:1040-105

Davidoff DF, Luxford C, Kim E, Novos T, Horvath R, Gill AJ, Benn DE, Dwight T, Clifton-Bligh RJ, Burgess JR Measuring tumor succinate and fumarate to resolve pathogenicity of an SDHA variant Clinical Chemistry 2021; 67:696–699

Wietsma MFT, Mooly C, Bhimani N, de Savornin Lohman, Gill AJ, Andrici J, Samra J, de Reuver PR, Hugh TJ Gallbadder Carcinoma Outcomes in an Australian Tertiary Referral Hospital ANZ J Surgery ANZ J Surgery 2021; 91:603-608

Jaffar S, Jayasekara J, Annis AM, Tsan VHM, Learoyd DL, Clifton-Bligh R, Gill AJ, Glover AR, Sidhu SB, Robinson B, Sywak M Predicting Distant Metastatic Disease in Differentiated Thyroid Cancer: A Matched Case-Control Study ANZ J Surgery 2021; 91:716-723

Vargas AC, Burchett I, Turner J, Delprado W, Brookwell R, Chalasani V, Gill AJ, Maclean FM Monotypic plasma cell proliferation of uncertain clinical significance mimicking interstitial cystitis: an early lesion of MALT lymphoma? American Journal of Surgical Pathology 2021; 45:841-853

Vargas AC, Ardakani NM, Wong DD, Maclean F, Kattampallil J, Boyle R, Santos L, Gill AJ Chromosomal imbalances detected in NTRK-rearranged sarcomas by comparative genomic hybridization Histopathology 2021; 78:932-942

​

​

​

​

Nagtegaal ID, Odze RD,  Klimstra D, Paradis V,  Rugge M,  Schirmacher P,  Washington MK, Carneiro F, Cree IA, for the WHO Editorial Board The 2019 WHO classification of tumours of the digestive system Histopathology 2020 Jan;76(2):182-188.

Chan JCY, Diakos CI, Engel A, Chan DLH, Pavlakis N, Gill AJ, Clarke SJ Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer PlosOne 2020 Jan 30;15(1):e0228466

Lau HD, Chan E, Fan AC, Kunder CA, Williamson SR, Zhou M, Idrees MT, Maclean FM, Gill AJ, Kao CS A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-Deficient Renal Cell Carcinoma in 32 Patients American Journal of Surgical Pathology 2020;44:98–110

The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium Pan-cancer analysis of whole genomes Nature 2020; 578:82-93

Turchini J, Gill AJ Morphological clues to succinate dehydrogenase (SDH) deficiency in pheochromocytomas and paragangliomas American Journal of Surgical Pathology 2020 44(3):422-424

Fuchs TL, Sison L, Sheen A, Jafari-Nejad K, Renaud CJ, Andrici J, Ahadi M, Chou A, Gill AJ Assessment of tumor infiltrating lymphocytes using International TILs Working Group (ITWG) system is a strong predictor of overall survival in colorectal carcinoma – a study of 1034 patients American Journal of Surgical Pathology 2020;44:536-544

Itchins M, Chua TC, Arena J, Jamieson NB, Nahm CB, O’Connell R, Bailey E, Schembri G, Gill AJ, Kneebone A, Hruby G, Mittal A, Pavlakis N, Clarke SJ, Samra JS Evaluation of fluorodeoxyglucose positron emission tomography (FDG PET) scanning in the neoadjuvant therapy paradigm in pancreatic ductal adenocarcinoma (PDAC)  Pancreas 2020 Feb;49(2):224-229

Pulvers J, Guminski A, Chou A, Gill AJ, Ahadi M Decoding a mysterious morphology with molecular pathology: Chondroid metaplasia in a metastatic gastrointestinal stromal tumour after imatinib therapy Pathology 2020; 52:396–398

Fraser T, Mittal A, Samra J, Chou A, Gill AJ Routine NTRK immunohistochemistry is not a useful screening strategy in unselected pancreatic carcinomas Pathology 2020; 52:398–400

Chou A, Brown IS, Kumarasinghe MP, Perren A, Riley D, Kim Y, Pajic M, Steinmann A, Rathi V, Jamieson NB, Verheij J, van Roessel S, Nahm CV, Mittal A, Samra JS, Gill AJ RET gene rearrangements occur in a subset of pancreatic acinar cell carcinomas Modern Pathology 2020; 33:657–664

Keane C, Law SC, Gould C, Birch S, Sabdia MB, de Long M, Thillaiyampalam G, Abro E, Tobin JW, Tan X, Xu-Monette ZY, Young KH, Gifford G, Gabreilli S, Stevenson WS, Gill AJ, Talaulikar D, Jain S, Hernandez A, Halliday SJ, Bird R, Cross D, Hertzberg M, Gandhi MK. LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma Blood Adv. 2020;4(7):1367-1377.

Castillo L, Young AIJ, Mawson A, Schafranek P, Steinmann AM, Nessem D, Parkin A, Johns A, Chou A, Law AMK, Lucas MC, Murphy KJ, Deng N, Gallego-Ortega D, Caldon CE, Australian Pancreatic Cancer Genome Initiative (APGI), Timpson P, Pajic M, Ormandy CJ, Oakes SR MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma Oncogene 2020 Feb;39(8):1821-1829.

Zaborowski M, Ahadi M, Sywak M, Nylén C, Gill AJ*, Chou A* Unique and distinctive histological features of immunotherapy-related thyroiditis Pathology 2020 Feb;52(2):271-273

Krawitz R, Glover A, Koneru S, Jiang J, Di Marco A, Gill AJ, Aniss A, Sywak M, Delbridge L, Sidhu S The significance of histologically “large normal” parathyroid glands in primary hyperparathyroidism World Journal of Surgery . 2020;44(4):1149-1155

Vargas AC, Maclean FM, Sioson L, Tran D, Bonar F, Mahar A, Cheah A, Russell P, Grimison P, Richardson L, Gill AJ  Prevalence of PD-L1 expression in matched recurrent and/or metastatic sarcoma samples and in a range of selected sarcoma subtypes PloseOne 2020;15(4):e0222551

Nahm CB, Parker N, Gundara JS, Gill AJ, Bhimani N, Samra JS, Hugh TJ Management of Patients with Hepatocellular Adenoma: A Single Institution Experience ANZ J Surgery 2020 May;90(5):786-790

Sahni S, Nahm C, Krisp C, Molloy MP, Mehta S, Maloney S, Ithins S, Pavlakis N, Clarke S, Chan D, Gill AJ, Howell VM, Samra JS, Mittal A Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant Chemotherapy Frontiers in Oncology 2020 Mar 4;10:237

Chou A, Fraser T, Ahadi M, Fuchs T, Sioson L, Clarkson A, Sheen A, Singh N, Corless CL, Gill AJ NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas – a study of 4569 cases Modern Pathology 2020;33:924-932

Xu B, Chang K, Folpe AL, Kao Y-C, Wey S-L, Huang H-Y, Gill AJ, Rooper L, Bishop JA, Dickson BC, Lee J-C, Antonescu CR Head and Neck Mesenchymal Neoplasms With GLI1 Gene Alterations: A Pathologic Entity With Distinct Histologic Features and Potential for Distant Metastasis Am J Surg Pathol  2020;44:729-737

Brunton H, Caligiuri G, Cunningham R, Upstill-Goddard R, Bailey UM, Garner IM, Nourse C, Dreyer S, Jones M, Moran-Jones K, Wright DW, Paulus-Hock V, Nixon C, Thomson G, Jamieson NB, McGregor GA, Evers L, McKay CJ, Gulati A, Brough R, Bajrami I, Pettitt SJ, Dziubinski ML, Barry ST, Grützmann R, Brown R, Curry E; Glasgow Precision Oncology Laboratory; Australian Pancreatic Cancer Genome Initiative, Pajic M, Musgrove EA, Petersen GM, Shanks E, Ashworth A, Crawford HC, Simeone DM, Froeling FEM, Lord CJ, Mukhopadhyay D, Pilarsky C, Grimmond SE, Morton JP, Sansom OJ, Chang DK, Bailey PJ, Biankin AV  HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer. Cell Rep. 2020 May 12;31:107625

Kim H, Lapuk A, Harraway J, Lee E, Walsh M, Topkas E, Jones V, Burn J, Baillie T, Lim C, Nejad K, Muljono A, Gagne E, McConechy MK, Zein Y, MacLean F, Gill AJ, Vargas AC  Prevalence of the EGFR T790M and other resistance mutations in the Australian population and histopathological correlation in a small subset of cases  Pathology 2020;52:410-420

Wong DD, Vargas AC, Bonar F, Maclean F, Kattampallil J, Stewart C, Sulaiman B, Santos L, Gill AJ NTRK-rearranged mesenchymal tumours: diagnostic challenges, morphological patterns and immunoprofiles Pathology 2020;52:401-40

Vargas AC, Wong DD, Bonar F, MacLean F, Qiu MR, Boyle R, Gill AJ A ‘Double Hit’ translocation sarcoma – first report of the co-occurrence of EWSR1-FLI1 and MTMR2-NTRK2 fusion in a small round blue cell sarcoma  AJSP: Reviews and Reports 2020; 25:97-100

Mehta S, Tan GI, Nahm CB, Chua TC, Pearson A, Gill AJ, Samra JS, Mittal A Pancreatic resection in patients with a synchronous extra-pancreatic malignancy: Outcomes and complications ANZ J Surgery 2020 Mar;90(3):290-294.

Haines M, Chua TC, Jamieson NB, Mittal A, Gill AJ, Samra JS Pancreatoduodenectomy with Arterial Resection for Locally Advanced Pancreatic Cancer of the Head: A Systematic Review Pancreas 2020;49:621-628

Agaimy A, Skalova A, Franchi A, Alshaground R, Gill AJ, Stoehr R, Baumhoer, D, Bauer S Ameloblastic Fibrosarcoma: Clinicopathological and Molecular Analysis of 7 Cases Highlighting Frequent BRAF and Rare NRAS Mutations Histopathology May;76(6):814-821

van Roessel S, Strijker M, Steyerberg EW, Groen JV, J. Mieog S, Groot VP, He J, Pastena MD, Marchegiani G, Bassi C, Jang J-Y, Busch OR, Halimi A,  Zarantonello L, Koerkamp BG, Samra JS, Mittal A, Gill AJ, Wellner U, van Eijck CH, Hilal MA, del Chiaro M, Keck T, Alseidi A, Wolfgang CL,  Malleo G, Besselink MG

International Validation and Update of the Amsterdam Model for Prediction of Survival after Pancreatoduodenectomy for Pancreatic Cancer European Journal of Surgical Oncology 2020 May;46(5):796-803

Turchini J, Sioson L, Clarkson A, Sheen A, Gill AJ Utility of GATA-3 expression in the analysis of pituitary neuroendocrine tumor (PitNET) transcription factors Endocrine Pathology 2020; 31:150-155

Fuchs TL, Chou A, Sioson L, Sheen A, Gill AJ Stromal tumour-infiltrating lymphocytes (TILs) assessed using the ITWG system do not predict overall survival in a cohort of 337 cases of mesothelioma Histopathology 2020; 76:1095-1101

Williamson SR, Gill AJ, Argani P, Chen Y-B, Egevad L, Kristiansen G, Grignon DJ, Hes O Report from the International Society of Urological Pathology (ISUP) Consultation Conference On Molecular Pathology Of Urogenital Cancers. III. Molecular Pathology of Kidney Cancer American Journal of Surgical Pathology 2020;44:e47-e65

Itchins M, Lau B, Hudson AL, Westman H, Xia CY, Hayes SA, Howell VM, Rodriguez M, Cooper W, Wei H, Buckland M, Li BT, Li M, Rathi V, Fox SB, Gill AJ, Clarke SJ, Boyer M, Pavlakis N ALK-Rearranged Non-Small Cell Lung Cancer in 2020: Real-World Triumphs in an Era of Multigeneration ALK-Inhibitor Sequencing Informed by Drug Resistance Profiling The Oncologist 2020;25:1–9

Wong MYW, Wong MG, Stangenberg S, Jarolimek W, Shilter H, Zakry A, Gill AJ, Pollock C, Saad S Semicarbazide-sensitive amine oxidase inhibition ameliorates albuminuria and glomerulosclerosis but does not improve tubulointerstitial fibrosis in diabetic nephropathy PlosOne 2020;15(6):e0234617

Wallace PW, Conrad C, Brueckmann S, Pang Y, Caleiras E, Murakami M, Korpershoek E, Zhuang Z, Rapizzi E, Kroiss M, Gudziol V, Timmers HJLM, Mannelli M, Pietzsch J, Beuschlein F, Pacak K, Robledo M, Klink B, Peitzsch M, Gill AJ, Tischler AS, de Krijger RR, Papathomas T, Aust D, Eisenhofer G, Richter S Metabolomics, machine learning, and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas Journal of Pathology 2020; 251:378-587

Dreyer SB, Pinese M, Jamieson NB, Scarlett CJ, Colvin EK, Pajic M, Johns AL, Humphris JL, Wu J, Cowley MJ, Chou A, Nagrial AM, Chantrill L, Chin VT, Jones MD, Moran-Jones K, Carter CR, Dickson EJ, Samra JS, Merrett ND, Gill AJ, Kench JG, Duthie F, Miller DK, Cooke S, Aust D,  Knösel T, Rümmele P, Grützmann R, Pilarsky C, Nguyen NQ, Musgrove EA, Bailey PJ, McKay CJ, Biankin AV, Chang DK; Australian Pancreatic Cancer Genome Initiative; Glasgow Precision Oncology Laboratory Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer Annals of Surgery 2020;272:366-376.

Kokkinos J, Mistica R, Ignacio C, Sharbeen G, Boyer C, Gonzales-Aloy E, Goldstein D, McCarroll JA, Phillips PA, Australian Pancreatic Genome Initiative, Johns AL, Gill AJ, Chang DK, Chantrill LA, Chou A, Pajic M, Steinmann A, Arshi M, Drury A, Froio D, Parkin A, Timpson P, Hermann D, Waddell N, Pearson JV, Patch A-M, Nones K, Newell F, Mukhopadhyay P, Addala V, Kazakoff S, Holmes O, Leonard O, Wood S, Xu C, Grimmond SM, Hofman O, Christ A, Bruxner T, Samra JS, Arena J, Pavlakis N, High HA, Mittal A, Asghari R, Merrett ND, Pavey D, Das A, Cosman PH, Ismail K, O’Connor C, Stoita A, Williams D, Spigellman A, Lam VW, McLeod D, Nagrrial Am, Kirk J, Kench JG, Grimison P, Cooper CL, Sandroussi C, Goodwin A, Mead RS, Tucker K, Andrews L, Texler M, Forest C, Epari KP, Ballal M, Fletcher DR, Mukhedar S, Zeps N, Beilin M, Feeney K, Nguyen NQ, Ruszkiewicz AR, Worthley C, Chen J, Brooke-Smith ME, Papangelis V, Clouston AD, Martin P, Barbour AP, O’Rourke TJ, Fawcett JW, Slater K, Hatzifotis M, Hodgkinson P, Nikfarjam M, Eshleman JR, Hruban RH, Wolfgang CL, Hodgin M, Scarpa A, Lawlor RT, Beghelli S, Corbo V, Scardoni M, Bassi C, Biankin AV, Dixon J, Nourse C, Jamieson NB Targeting the Undruggable in Pancreatic Cancer Using Nano-Based Gene Silencing Drugs Biomaterials 2020;240:119742.

Fuchs TL, Pearson A, Pickett J, Diakos C, Dewar R, Chan D, Guminski A, Menzies A, Baron-Hay S, Sheen A, Sioson L, Chou A, Gill AJ Why pathologists and oncologists should know about tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer: an Australian experience of 139 cases Pathology 2020; 52:515-521

Turchini J, Gill AJ Hereditary parathyroid disease: Sometimes pathologists do not know what they are missing Endocrine Pathology 2020; 31:218–230

Nylén C, Mecher R, Marechal-Ross I, Tsang V, Chou A, Gill AJ, Clifton-Bligh RJ, Robinson BG, Sywak MS, Sidhu SB, Glover AR Molecular markers guiding thyroid cancer management Cancers 2020; 12:2164

Carter AM, Tan C, Poso K, Relange R, Molinaro R, Guo A, de Rosa E, Martinez JO, Zhang S, Kumar N, Takahashi M, Wiederhold T, Ghayee HK, Oltmann SC, Pacak K, Woltering EA, Hatanpaa KJ, Nwariaku FE, Grubbs EG, Gill AJ, Robinson B, Gillardon F, Reddy S, Jaskula-Sztul R, Mobely JA, Mukhtar MS, Tasciotti E, Chen H, Bibb JA Phosphoprotein-based Biomarkers as Predictors for Cancer Therapy PNAS 2020;117(31):18401-18411

Sahni S, Miller E, Howell VM, Mehta S, Pavlakis N, Chan D, Ahadi M, Gill AJ, Samra J, Mittal A Tissue Biomarker Panel as a Surrogate Marker for Squamous Subtype of Pancreatic Cancer European Journal of Surgical Oncology 2020;46(8):1539-1542

Noel M, Nicknafs N, Fischer CG, Hackengl WM, Guthrie VB, Hosodal W, Debeljak M, Papp E, Adleff V, White JR, Luchin C, Pea A, Scarpa A, Butturini G, Zamboni G, Castelli P, Hong S-M, Yachida S, Hiraoka N, Gill AJ, Samra JS, Offerhous GJA, Hoorens A, Verheij J, Jansen C, Adsay NV, Jian WJ, Winter J, Albores-Saavedra J, Terris B, Thompson ED, Roberts NJ, Hruban RH, Karchin R, Scharpf R, Brosens LAA, Velculescu VE, Wood LD Genomic characterization of malignant progression in neoplastic pancreatic cysts Nature Communications 2020; 11:4085 https://doi.org/10.1038/s41467-020-17917-8

Bailey MH, Meyerson WU, Dursi LJ, Wang LB, Dong G, Liang WW, Weerasinghe A, Li S, Li Y, Kelso S; MC3 Working Group; PCAWG novel somatic mutation calling methods working group, Saksena G, Ellrott K, Wendl MC, Wheeler DA, Getz G, Simpson JT, Gerstein MB, Ding L; PCAWG Consortium. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. Nat Commun 2020;11:4748

Gifford GK, Gifford AJ, Chen Q, Shen Y, Gabrielli S, Gill AJ, Stevenson WS, Best OG Fatty acid synthase and adenosine monophosphate-activated protein kinase regulate cell survival and drug-sensitivity in diffuse large B-cell lymphoma Leukemia and Lymphoma 2020; 61(8):1810-182

Prall OWJ, Nastevski V, Xu H, McEvoy CR, Vissers JHA, Byrne DJ, Takano E, Yerneni S, Ellis S, Green T, Mitchell CA, Murray WK, Scott CL, Grimmond SM, Hofman O, Papenfuss A, Kee D, Fellowes A, Brown IS, Miller G, Kumarasinghe MP, Perren A, Nahm CB, Mittal A, Samra J, Ahadi M, Fox SB, Chou A, Gill AJ RAF1 rearrangements are common in pancreatic acinar cell carcinomas Modern Pathology 2020; 33:1811-1821

Fuchs TL, Nassour AJ, Glover A, Sywak MS, Sidhu SB, Delbridge LW, Clifton-Bligh RJ, Gilld ML, Tsang V, Robinson BG, Clarkson A, Sheen A, Sioson L, Chou A, Gill AJ

A proposed grading scheme for medullary thyroid carcinoma based on proliferative activity (Ki67 and mitotic count) and coagulative necrosis American Journal of Surgical Pathology 2020; 44:1419-1428

Ahmadzada T, Cooper WA, Holmes M, Mahar A, Westman H, Gill AJ, Nordman I, Yip PY, Pal A, Zielinski R, Pavlakis N, Nagrial A, Daneshvar D, Brungs D, Karikos D, Aleksova V, Burn J, Asher R, Grauel GE, Hosseini-Beheshti E, Reid G, Clark S, Kao S Retrospective evaluation of the use of pembrolizumab in malignant mesothelioma in a real-world Australian population JTO Clinical and Research Reports 2020; 1: 1–15

Tan PH, Ellis I, Allison K, Brogi E, Lakhani S, Laza AJ, Morris EA, Aysegul S, Salgado R, Sapino A, Sasano H, Schnitt S, Sotiriou C, can Diese P, White VA, Lokuhetti D, Cree IA, The WHO Classification of Tumours Editorial Board The 2019 WHO classification of tumours of the breast Histopathology 2020 Aug;77(2):181-185

Xu B, Fuchs T, Dogan S, Landa-Lopez I, Katabi N, Fagin JA, Tuttle RM, Sherman E, Gill AJ, Ghossein R Dissecting Anaplastic Thyroid Carcinoma (ATC): A Comprehensive Clinicohistologic, Immunophenotypic, and Molecular Studies of 360 Cases Thyroid 2020 Oct;30(10):1505-1517.

Rykina-Tameeva N, Nahm CB, Mehta S, Gill AJ, Samra JS, Mittal A Neoadjuvant therapy for pancreatic cancer changes the composition of the pancreatic parenchyma HPB Journal 2020;22:1631-1636

Li CH, Prokopec SD, Sun RX, Yousif F, Schmitz N, PCAWG Tumour Subtypes and Clinical Translation, Paul C. Boutros & PCAWG Consortium  Sex differences in oncogenic mutational processes. Nat Commun 2020;11:4330

Zaborowski M, Vargas AC, Pulvers J, Clarkson A, de Guzman D, Sioson L, Maclean F, Chou A, Gill AJ When used together SS18-SSX fusion-specific and SSX C-terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in most cases Histopathology 2020 Oct;77(4):588-600.

Weppler AM, Pattison A, Bhaye PI, De Ieso PB, Raleigh JI, Hatzimihalis A, Gill AJ, Balachander S, Callahan J, Chua MS-T, Au Yeung G, McArthur GA, Hicks RJ, Tothil RW, Sandhu S Clinical, FDG-PET and Molecular Markers of Immune Checkpoint Inhibitor Response in Patients with Metastatic Merkel Cell Carcinoma  J Immunother Cancer. 2020 Oct;8(2):e000700. doi: 10.1136/jitc-2020-000700

Zhao Y, Pan Z, Namburi S, Pattison A, Posner A, Balachander S, Paisie CA, Reddy HV, Rueter J, Gill AJ, Fox S, Raghav KPS, Flynn WF, Tothill RW, Li S, Karuturi RKM, George J CUP-AI-Dx: a tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence EBioMedicine 2020; 61:103030

Sahni S, Krisp C, Molloy MP, Nahm C, Gillson J, Gill AJ, Samra J, Mittal A  PSMD11, PTPRM and PTPRB as Novel Biomarkers of Pancreatic Cancer Progression Biochim Biophys Acta Gen Subj. 2020;1864:129682

Smith RC, Bulanadil JC, Gill AJ, Rye K-A, Hugh T, Proschogo N, Smith SF, Phillips L, Gong X, Jolovil SM, Xue A, Moghaddam M Pancreatic adenocarcinoma preferentially takes up and is suppressed by synthetic nanoparticles carrying Apolipoprotein A-II and a lipid gemcitabine prodrug in mice Cancer Letters 2020;495:112-122

​

​

​

​

Taylor A, Eade T, Veivers D, Gill AJ, Pang L Human papillomavirus and oropharyngeal squamous cell carcinoma: a 12-year retrospective review in a New South Wales tertiary referral centre Aust J Otolaryngol 2019;2:1

Foix P, Pitra T, Martinek P, Micsik T, Berney D, Gill AJ, Magi-Galluzzi C, Mareckova J, Grossman P, Mundo EC, Polivka J, Alaghehbandan R, Michalova K, Rogla J, Trpkov K, Rychly B, Michal M, Hora M, Isikci OT, Skalova S, Pivovarciova K, Hes O Fumarate hydratase deficient renal cell carcinoma: Chromosomal numerical aberration analysis of 12 cases. Annals of Diagnostic Pathology 2019; 39:63-68

Gill AJ, Lim G, Cheung VKY, Andrici J, Perry-Keene JL, Paik J, Sioson L, Clarkson A, Sheen A, Luxford C, Elston MS, Meyer-Rochow GY, Nano MT, Kruijff S, Engelsman AF, Sywak M, Sidhu SB, Delbridge LW, Robinson BG, Marsh DJ, Toon CW, Chou A, Clifton-Bligh RJ Parafibromin deficient (HPT-JT type, CDC73 mutated) parathyroid tumors demonstrate distinctive morphological features American Journal of Surgical Pathology 2019;43:35–46

Nahm CB, Turchini J, Jamieson NB, Moon E, Sioson L, Itchins M, Arena J, Colvin E, Howell VM, Pavlakis N, Clarke S, Samra JS, Gill AJ, Mittal A. Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: a multi-institutional cohort study European Journal of Surgical Oncology 2019; 45:218-224

Schlichtemeier SM, Nahm CB, Xue A, Gill AJ, Smith RC, Hugh TJ  SELDI-TOF MS Analysis of Hepatocellular Carcinoma in an Australian Cohort Journal of Surgical Research 2019; 238:127-136

Chua T, Singh G, Nahm CB, Jamieson NB, Wong S, Thoo C, Mittal A, Gill AJ, Samra JS Management of Post-Pancreatectomy Haemorrhage using Resuscitative Endovascular Balloon Occlusion of the Aorta Archives of Surgery 2019; 404:253–255

Phillips L, Gill AJ, Baxter R Novel Prognostic Markers in Triple-Negative Breast Cancer Discovered by MALDI-Mass Spectrometry Imaging  Front. Oncol 2019;9:379

doi: 10.3389/fonc.2019.00379

Yozu M, Kumarasinghe MP, Brown IS, Gill AJ, Rosty C Australasian Gastrointestinal Pathology Society (AGPS) Consensus Guidelines for Universal Defective Mismatch Repair Testing in Colorectal Carcinoma Pathology 2019; 51:233–239

Zabrowski M, Pearson A, Sioson L, Gill AJ, Ahadi MS Androgen receptor immunoexpression in Triple-Negative breast cancers: is it a prognostic factor?  Pathology 2019; 51:327-329

Nahm CB, Lui I, Roseverne L, Naido CS, Alzaabil S, Maher R, Mann G, Blome S, Gill AJ, Samra JS, Mittal A Density and enhancement of the pancreatic tail on computer tomography predicts acinar score and pancreatic fistula after pancreatoduodenectomy HPB 2019;21:604-611.

Fuchs TL, Bell SE, Chou A, Gill AJ Revisiting the significance of prominent C-cells in the thyroid Endocrine Pathology 2019; 30:113-117

Gill P, Kim E, Chua TC, Clifton-Bligh RJ, Nahm CB, Mittal A, Gill AJ*, Samra JS* MiRNA-3653 is a Potential Tissue Biomarker for Increased Metastatic Risk in Pancreatic Neuroendocrine Tumours Endocrine Pathology 2019; 30:128-133

Nahm CB, Nejdawi F, Reagh J, Kaufman A, Mittal A, Gill AJ, Samra J Pancreatic Hamartoma – A Sheep in Wolf’s Clothing ANZ J Surg 2019; 89:E265-E267

Joo LJS, Weiss J, Gill AJ, Clifton-Bligh R, Brahmbhatt H, MacDiarmid JA, Gild ML, Robinson BG, Zhao JT, Sidhu SB RET kinase-regulated microRNA-153-3p improves therapeutic efficacy in medullary thyroid carcinoma  Thyroid 2019; 29:830-844

Chan JCY, Diakos CI, Engel A, Chan DLH, Pavlakis N, Gill AJ, Clarke SJ Tumor sidedness is not an independent prognostic marker of colorectal cancer patients undergoing curative resection: a retrospective cohort study PlosOne 2019 Jun 12;14(6):e0218207.

Kwok GTY, Zhao JT, Glover AR, Gill AJ, Clifton-Bligh R, Robinson BG, Ip JCY, Sidhu SB MicroRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma The Oncologist 2019; 24:e241-e250

Ahadi SM, Gill AJ SMARCA4 loss is very rare in thoracic mesothelioma American Journal of Surgical Pathology 2019; 43:1154-1155

Morrow A, Hogden E, Kang YJ, Steinberg J, Canfell K, Solomon MH, Kench JG, Gill AJ, Shaw T, Pachter N, Parkinson B, Wolfenden L, Mitchell G, Macrae F, Tucker K, Taylor N Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol Trials 2019;20:373

Vennin  C, Mélénec P, Rouet R, Nobis M, Cazet AS, Murphy KJ, Herrmann D, Reed DA, 2, Lucas MC, Warren SC, Elgundi Z, Pinese M, Kalna G, Roden D, Samuel M,

Zaratzian A, Grey S, Da Silva A, Leung W, Australian Pancreatic Genome Initiative (APGI), Mathivanan S, Wang Y, Braithwaite AW, Christ D, Benda A, Parkin A, Phillips PA, Whitelock JM, Gill AJ, Sansom OJ, Croucher DR, Parker BL, Pajic M, Morton JP, Cox TR*Timpson P* CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan Nature Communications  2019; 10:3637

Keane C, Gunawardana J, Santiyagu F, Gifford G, Gabrielli S, Gill AJ, Stevenson W, Talaulikar D, Jain S, Gould C, Birch S, Hertzberg M, Gandhi  The tumor microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV positive Diffuse Large B Cell Lymphoma European Journal of Haematology 2019; 103:200-207

Bolzacchini E, Digiacomo N, Marrazzo C, Sahnane N, Maragliano R, Gill AJ, Albarello L, Sessa F, Furlan D, Capella C BRAF mutation in colorectal rhabdoid poorly differentiated medullary carcinomas Cancers 2019; 11(9), 1252; https://doi.org/10.3390/cancers11091252

Bettington ML, Liu C, Gill AJ, Walker NI, Leggett BA, Whitehall VLJ, Rosty C BRAF V600E immunohistochemistry demonstrates that some sessile serrated lesions with adenomatous dysplasia may represent collision lesions Histopathology 2019;75:81-87

Trpkov K, Bonert M, Gao Y, Kappor A, He H, Yilmaz S, Gill AJ, Williamson SR, Comperat E, Tretiakova M, Magi-Galluzzi C, Brimo F, Hes O

High-grade Oncocytic Tumor (HOT) of Kidney in a Patient with Tuberous Sclerosis Complex Histopathology 2019;75:440-442.

Sun N, Kunzkel T, Sbiera S, Kircher S, Feuchtinger A, Aichler M, Herterich S, Conchi CL, Weigand I, Shleger N, Waldman J, Fragosos MCV, Whitsett TG, Gill AJ, Fassnacht F, Walch A, Kroiss B Prognostic Relevance of Steroid Sulfation in Adrenocortical Carcinoma Revealed by Molecular Phenotyping Using High-Resolution Mass Spectrometry Imaging Clinical Chemistry 2019; 65:1276–1286

Pivovarčíková K, Martínek P, Trpkov K, Alaghehbandan R, Magi-Galluzzi C, Mundo EC, Berney D, Suster S, Gill A, Rychlý B, Michalová K, Pitra T, Hora M, Michal M, Hes O  Fumarate hydratase deficient renal cell carcinoma and fumarate hydratase deficient-like renal cell carcinoma: Morphologic comparative study of 23 genetically tested cases. Cesk Patol. 2019;55:244-249

Zaborowski M, Gill AJ Is secretory breast carcinoma underdiagnosed? In the era of targeted therapy should there be a low threshold to screen for NTRK immunohistochemistry in triple negative breast cancers? Pathology 2019;51:653–655

Vargas AC, Maclean FM, Bonar F, Mahar A, Gill AJ NR4A3 immunohistochemistry lacks sensitivity for the diagnosis of extraskeletal myxoid chondrosarcoma American Journal of Surgical Pathology 2019; 43:1726-1728

Lopez-Campistrous A, Theissen A, Gill AJ, Ghosh S, McMullen TPW Loss of nuclear localization of thyroid transcription factor 1 and adverse outcomes in papillary thyroid Cancer Human Pathology  2019;91:36-42

​

​

​

​

Gill AJ, Barletta JA Annual review issue : Endocrine pathology: a pathological, clinical and molecular integration Histopathology 2018; 72:3

Gill AJ Succinate dehydrogenase (SDH) deficient neoplasia Histopathology 2018; 72:106–116

Turchini J, Cheung VKY, Tischler AS, De Krijger RR Gill AJ Pathology and Genetics of Phaeochromocytoma and Paraganglioma Histopathology 2018; 72:97–105

Dwight T, Flynn A, Amarasinghe K, Benn DE, Lupat R, Li J, Cameron DL, Hogg A, Balachander S, Candiloro ILM, Wong SQ, Robinson BG, Papenfuss AT, Gill AJ, Dobrovic A, Hicks RJ, Clifton-Bligh RJ, Tothill RW TERT structural rearrangements in metastatic pheochromocytomas Endocrine Related Cancer 2018;25:1-9

Chou A, Toon CW, Clarkson A, Sheen A, Sioson L, Gill AJ The epithelioid, BAP1-negative and p16-positive phenotype predicts prolonged survival in pleural mesothelioma Histopathology 2018; 72:509-515

Dreyer SB, Jamieson NB, Upstill-Goddard R, Bailey PJ, McKay CJ; Australian Pancreatic Cancer Genome Initiative, Biankin AV, Chang DK Defining the molecular pathology of pancreatic body and tail adenocarcinoma Br J Surg. 2018; 105:e183-e191

Ohe C, Smith SC, Sirohi D, Dibatia M, de Peralta-Venturina M, Paner GP, Agaimy A, Amin MB, Argani P, Chen Y-B, Cheng L, Colecchia M, Comperat E, Werneck Da Cunha I, Epstein JL, Gill AJ, Hes O, Hirsch MS, Wolfram J, Kunjy LP, Maclean F, Magi-Galuzzi C, McKenney JK, Mehra R, Nesi G, Osunkoya AO, Picken MM, Rao P, Reuter VE, de Oliveira S, Guilherme P Schultaz L, Tickoo SK, Tomlins SA, Scott A, Trpkov K, Amin MB Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase–deficient Renal Cell Carcinoma Am J Surg Pathol 2018; 42:279-292

Bettison TM, Nahm CB, Gill AJ, Mittal A, Malhi GS, Samra JS, Understanding the Pathophysiology of Psychological Distress and Pancreatic Cancer: A Systematic Review Pancreas 2018 Apr;47(4):376-38

Gifford G, Gabrielli S, Gill AJ, Greenwood M, Wong K, Best G, Nevell D, McIlroy K, Kliman D, Ilmay-Gillespie L, Tiley C, Miranda S, Armytage T, Stevenson W Lymphoma cell-of–origin assignment by gene expression profiling is clinically meaningful across broad laboratory contexts British Journal of Haematology 2018: 181: 272–275

Jayakody S, Reagh J, Bullock M, Aniss A, Clifton-Bligh R, Learoyd D, Robinson B, Delbridge L, Sidhu S, Gill AJ, Sywak M Medullary Thyroid Carcinoma: Survival Analysis and Evaluation of Mutation-Specific Immunohistochemistry in Detection of Sporadic Disease World J Surg. 2018 May;42(5):1432-1439.

Foo E, Turner R, Wang K-C, Annis A, Gill AJ, Sidhu SB, Clifton-Bligh RJ, Sywak M Predicting malignancy in adrenal incidentaloma and evaluation of a novel risk stratification algorithm ANZ Journal of Surgery 2018; 88(3), E173-E177

Gill P, Chua TC, Huang Y, Mehta S, Mittal A, Gill AJ, Samra JS Pancreatoduodenectomy and the risk of complication from perioperative fluid administration ANZ J Surg 2018;88(4):E318-E323

Oh LJ, Wong E, Gill AJ, McCluskey P, Smith JE Value of temporal artery biopsy length in diagnosing Giant Cell Arteritis ANZ J Surgery 2018; 88(3), 191-195

Townend P, de Reuver P, Chua T, Mittal A, Clarke SJ, Pavlakis N, Gill AJ, Samra JS Histopathological Tumor Viability After Neoadjuvant Chemotherapy Influences Survival in Resected Pancreatic Cancer ANZ J Surg 2018 Mar;88:E167-E172

Stangenberg S, Saad S, Schilter HC, Zaky A, Gill AJ, Pollock CA, Wong MG Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy. Sci Rep. 2018;21:8(1):9423.

Chou A, Kim Y, Samra JS, Pajic M, Gill AJ BRAF gene rearrangements can be identified by FISH studies in pancreatic acinar cell carcinoma Pathology 2018; 50:345–348

Oh LJ, Wong E, Andrici J, McCluskey P, Smith JEH, Gill AJ The full blood count as an ancillary test to support the diagnosis of giant cell arteritis Internal Medicine Journal 2018 Apr;48(4):408-413

Cheung VKY, Gill AJ,* Chou A* Old, new and emerging immunohistochemical markers in pheochromocytoma and paraganglioma Endocrine Pathology; 2018 29: 169-175

Andrici J, Gill AJ, Hornick JL Next Generation Immunohistochemistry: Emerging Substitutes to Genetic Testing? Seminars in Diagnostic Pathology 2018 May;35(3):161-169

Nahm C, Brown K, Townend PH, Colvin E, Howell VM, Hught TJ, Gill AJ, Connor S, Samra J, Mittal A Acinar cell density at the pancreatic resection margin is associated with post-pancreatectomy pancreatitis and the development of postoperative pancreatic fistula HPB (Oxford). 2018;20(5):432-440.

Fuchs TL, Sioson L, Sheen A, Clarkson A, Gill AJ Immunohistochemical expression of somatostatin receptors SSTR2A and SSTR5 in 299 pituitary adenomas Pathology 2018 Jun;50(4):472-474.

Chan JCY, Diakos CI, Chan DL, Engel A, Pavlakis N, Gill AJ, Clarke SJ A longitudinal investigation of inflammatory markers in colorectal cancer patients perioperatively demonstrates benefit in serial re-measurement Annals of Surgery 2018 Jun;267(6):1119-1125

Chua TC, Mittal A, Nahm C, Hugh TJ, Arena J, Gill AJ, Samra JS Pancreatoduodenectomy in a public versus private teaching hospital in Australia: outcomes are comparable with some minor variations ANZ J Surg 2018 Jun;88(6):E526-E531

Annamalai1 AK, Gill AJ, Shinto A, Sivakumar R, Singhi PK, Prabhu VA, Sridhar S, Shanthi R, Puri V, Gururaj N, Gopalakrishnan C, Chelian M, Srinivasan KG, Clifton-Bligh R, Gurnell M Oncogenic Osteomalacia QJM: An International Journal of Medicine 2018 Jun 1;111(6):421-422.

Agaimy A, Amin M, Gill AJ, Popp B, Berney DM, Magi-Galluzzi C, Sibny M, Smith SC, Suster S, Trpkov K, Hes O, Hartmann A SWI/SNF Protein Expression Status in Fumarate Hydratase-deficient Renal Cell Carcinoma: Immunohistochemical Analysis of 32 Tumors from 28 Patients Human Pathology 2018;77:139-146.

Brown KM, Xue A, Julovi S, Gill AJ, Pavlakis N, Samra JS, Smith RC, Hugh TJ Using patient-derived xenograft models of colorectal liver metastases to predict chemosensitivity Journal of Surgical Research 2018 Jul;227:158-16

Reagh J, Clarkson A, Bullock M, Shepherd P, Gill AJ Real world experience of BRAFV600E mutation specific immunohistochemistry in colorectal carcinoma Pathology September 2018;50:342–344

Gild ML, Tsang V, Samra J, Clifton-Bligh RJ, Tacon T, Gill AJ Hypercalcemia in glucagon cell hyperplasia and neoplasia (Mahvash syndrome): a new association Journal of Clinical Endocrinology and Metabolism 2018; 103:3119-3123

Chui J, Verdonk B, Gill AJ Loss of BAP1 expression occurs rarely to never colorectal adenocarcinoma Applied Immunohistochemistry and Molecular Morphology 2018 26;e91-e92

Chou A, Froio D, Nagrial AM, Morgan A, Murphy K, Chin VT, Wohl D, Steniman A, Stark R, Drury A, Walters S, Vennin C, Burgess A, Pinese M, Chantrill LA, Cowely M, Molloy TJ, Australian Pancreatic Cancer Genome Initiative (APGI), Wadddell N, Johns A, Grimmond SM, Chang DK, Biankin AV, Sanson OJ, Morton J, Grey ST, Cox TR, Turchini J, Samra J, Clark SJ, Timpson, Gill AJ, Pajic M Tailored first- and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer Gut 2018;67:2142–2155

Turchini J, Buckland ME, Gill AJ, Battye S Three-Dimensional Pathology Specimen Modeling Using "Structure-From-Motion" Photogrammetry: A Powerful New Tool for Surgical Pathology Arch Pathol Lab Med 2018;142:1415-1420

Parkin A, Man J, Chou A, Nagrial AM, Samra J, Gill AJ, Timpson P, Pajic M The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma  Diseases 2018, 6, 103; doi:10.3390/diseases6040103

Benn DE, Zhu Y, Andrews KA, Wilding M, Duncan EL, Dwight T, Tothill RW, Burgess J, Crook A, Gill AJ, Hicks RJ, Kim E, Luxford C, Marfan H, Richardson AL, Robinson B, Schlosberg A, Susman R, Tacon L, Trainer A, Tucker K, Maher ER, Field M, Clifton-Bligh RJ Bayesian approach to determining penetrance of pathogenic SDH variants J Med Genet 2018;55:729-734

He H, Trpkov K, Martinek P, Isikci OZ, Maggi-Galuzzi C, Alaghehbandan R, Gill AJ, Tretiakova M, Lopez JI, Williamson SR, Montiel DP, Sperga M, Comperat EM, Brimo F, Yilmazi A, Pivovarcikova K, Michalova K, Slouka D, Prochazkova K, Hora M, Bonert M, Michal M, Hes O High-grade Oncocytic Renal Tumor: Morphologic, Immunohistochemical and Molecular Genetic Study of 14 Cases Virchows Archive 2018;473:725-738

Lau J, Guminski A, Gill AJ, Veivers D Metastatic basal cell carcinoma: A Review of six cases Australian Journal of Otolaryngology 2018;1:20

Pinho AV, van Bulck M, Chantrill L, Arshi M, Sklyarova T, Herrmann D, Vennin C, Gallego-Ortegal D, Mawson A, Giry-Laterriere M, Magenou A, Leuckx G, Baeynes G, Gill AJ, Phillips P, Timpson P, Biankin AV, Wu J, Rooman I ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signaling Nature Communications 2018;9:5083

Shyu I, Mirsadraei L, Wang X, Robila V, Mehra R, Mchugh JB, Chen Y-B, Udager AM, Gill AJ, Cheng L, Amin MB, Lin O, Smith SC Clues to recognition of fumarate hydratase-deficient renal cell carcinoma: Findings from cytologic and limited biopsy samples Cancer Cytopathology 2018; 126:992-1002.

Chou A, Itchins M, de Reuver PR, Arena J, Clarkson A, Sheen A, Sioson L, Cheung V, Perren A, Nahm C, Mittal A, Samra JS, Pajic M, Gill AJ ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumours Human Pathology 2018;82:249-257

Itchins M, Hayes SA, Gill AJ, Cooper W, O’Connell RO, Howell VM, Clarke SJ, Pavlakis N Pattern of care and survival of anaplastic lymphoma kinase rearranged non–small cell lung cancer (ALK+ NSCLC) in an Australian Metropolitan Tertiary Referral Centre: A retrospective cohort analysis Asia-Pacific Journal of Clinical Oncology 2018;14:e275-e282

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Selinger CI, Li B, Pavlakis N, Links M, Lee A, Gill AJ, Lee A, Clarke S, Tran TN, Lum T, Yip PY, Horvath L, Kohonen-Corish MRH, O’Toole S, Cooper WA Screening for ROS1 gene rearrangements in non-small cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target Histopathology 2017;70(3):402-411

Hardie RA, van Dam E, Cowley M, Han TL, Balaban S, Pajic M, Pinese M, Iconomou M, Shearer RF, McKenna J, Miller D, Waddell N, Pearson JV, Grimmond SM; Australian Pancreatic Cancer Genome Initiative, Sazanov L, Biankin AV, Villas-Boas S, Hoy AJ, Turner N, Saunders DN Mitochondrial mutations and metabolic adaptation in pancreatic cancer Cancer Metab. 2017 Jan 30;5:2.

Wood SM, Gill AJ, Brodsky AS, Lu S, Friedman K, Karashchuk G, Lombardo K, Yang D, Resnick MB Fatty acid binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon γ pathway Modern Pathology 2017; 30(1):123-133

Reagh J, Bullock M, Andrici J, Turchini J, Sioson L, Clarkson A, Watson N, Sheen A, Lim G, Delbridge L, Sidhu S, Sywak M, Annis A, Shepherd P, Ng D, Oei P, Field M, Learoyd D, Robinson BG, Clifton-Bligh RJ, Gill AJ NRASQ61R mutation specific immunohistochemistry also identifies the HRASQ61R mutation in medullary thyroid cancer and may have a role in triaging genetic testing for MEN2 American Journal of Surgical Pathology 2017;41:75–81

Humphris JL, Patch A-M, Nones K, Bailey PJ, Johns AL, McKay S, Chang DK, Miller DK, Pajic M, Kassahn KS, Quinn MCJ, Bruxner TJC, Christ AN, Harliwong I, Idrisoglu S, Manning S, Nourse C,  Nourbakhsh E, Stone A, Wilson PJ, Anderson M, Fink JL, Holmes O, Kazakoff S, Leonard C, Newell F, Waddell N, Wood S, Mead RS, Xu Q, Wu J, Pinese M, Cowley MJ, Jones MD, Nagrial AM, Chin VT, Chantrill LA, Mawson A, Chou A, Scarlett CJ, Pinho AV, Rooman I, Giry-Laterrier M, Samra JS, Kench JG, Merrett ND, Toon CW, Epari K, Nguyen NQ, Barbour A, Zeps N, Jamieson NB, McKay CJ, Carter CR, Dickson EJ, Graham JS, Duthie F, Oien K, Hair J, Morton JP, Sansom OJ, Grutzmann R, Hruban RH, Maitra A, Iacubuzio-Donahue CA, Schulick RD, Wolfgang CL, Morgan RA, Lawlor RT, Rusev B, Corbo V, Salvia R, Cataldo I, Tortora G, Tempero MA, Australian Pancreatic Cancer Genome Initiative, Hofman O, Eshleman JR, Pilarsky C, Scarpa A, Musgrove EA, Gill AJ, Pearson JV, Grimmond SM, Waddell N, Biankin AV  Hypermutation in Pancreatic Cancer Gastroenterology 2017 Jan;152(1):68-74.e2

Kulkarni A, Gundara JS, Gill AJ, Hugh TJ, Samra JS Cholangiocarcinoma following external beam radiotherapy: A report of two cases Oncology Letters 2017;14.1: 423-426

Schlichtemeier S, Logari A, Gill AJ, Engel AF Colorectal Cancer Resection in the Australian Nonagenarian Patient Colorectal Disease 2017;19:243-250

Scarpa A, Chang DK, Nones K, Corbo V, Patch A-M, Bailey P, Lawlor RT, Johns AL, Miller DK, Mafficini A, Rusev B, Scardon M, Antonello D, Barbi S, Sikora KO, Cingarlin S, Vicentini C, Simpson S, Quinn MC, Bruxner TJC, Christ AN, Harliwong I, Idrisoglu S, Manning S, Nourse C, Nourbakhsh E, Wilson PJ, Anderson MJ, Fink JL, Newell F, Waddell N, Holmes O, Karzakoff SH, Leonard C, Wood S, Xy Q, Nagaraj SH, Amato E, Dalai I, Bersani S, Cataldo I, Capelli P, Davi MV, Landoni L, Malpaga A, Mitto M, Whitehall V, Leggett B, Khannan KK, Harris J, Jones MD, Humphris J, Chantrill LA, Chin V, Nagril A, Pajic M, Scarlett CJ, Pinho A, Rooman I, Toon C, Wu J, Pinese M, Cowley M, Giry-Laterriere M, Mawson A, Humphrey ES, Colvin EK, Chou A, Lovell JA, Jamieson NB, Duthie F, Gingras M-C, Muzny D, Dagg RA, Lau LMS, Lee M, Pickett HA, Reddel RR, Samra JS, Kench JG, Merrett ND, Epari K, Nguyen NQ, Zeps N, Falconi M, Simbolo M, Butturini G, Fassan M, A, Australian Pancreatic Cancer Genome Initiative, GillAJ, Wheeler DA, Gibbs RA, Musgrove EA, Bassi C, Tortora G, Pederzoli P, Pearson JV, Waddell N, Biankin AV, Grimmond SM Whole genome landscape of Pancreatic Neuroendocrine Tumours Nature 2017;543:65-71

Chan JCY, Chan D, Diakos C, Engel A, Pavlakis N, Gill AJ, Clarke S The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer Annals of Surgery 2017;265:539-546

Elston MS, Sehgal S, Dray M, Phillips E, Conaglen JV, Clifton-Bligh RJ, Gill AJ A duodenal SDH-deficient gastrointestinal stromal tumour in a patient with a germline SDHB mutation Journal of Clinical Endocrinology and Metabolism 2017 102:1447-1450

Vennin C, Chin VT, Warren SC, Morghan CL, Hermann D, Magenaul A, Melenec P, Walters SN, del Monte-Nieto G, Conway JRW, Nobis M, Allam AH, McCloy RA, Currey N, Pinese M, Boulghourjian A, Zaratzian A, Adam ASA, Heu C, Nagrial AM, Chou A, Steinmann A, Drury A, Froio D, Giry-Laterriere M, Harris NLE, Phan T, Jain R, Weninger W, McGhee EJ, Whan R, Johns AL, Samra JS, Chantrill L, Gill AJ, Kohonen-Corish M, Harvey RP, Biankin AV, Australian Pancreatic Genome Initiative (APGI), Evans TRJ, Anderson KI, Grey ST, Ormandy CJ, Gallego-Ortega D, Wang, Y, Samuel MS, Sansom OJ, Burgess A, Cox TR, Morton JP, Pajic M, Timpson P Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy and the onset of the metastatic niche Science Translational Medicine 2017;9(384). pii: eaai8504. doi: 10.1126/scitranslmed.aai8504.

Huang Y, Chua TC, Gill AJ, Samra JS  Impact of perioperative fluid administration on early outcomes after pancreatoduodenectomy: A meta-analysis. Pancreatology. 2017 May - Jun;17(3):334-341

Itchins M, Arena J, Pavlakis N, Nahm C, Gibbs E, Mohamudally A, Maher R, Blome S, Mann G, Bailey L, Schembri G, Gill AJ, Diakos C, Khasraw M, Hruby G, Kneebone A, Mittal A, Samra J, Clarke S Pattern of Care and Survival of Pancreatic Ductal

Adenocarcinoma in a Multi-Disciplinary High-Volume Centre Gastroenterol Hepatol Open Access. 2018;9(5):185‒189. DOI: 10.15406/ghoa.2018.09.00323

Hosoda W, Chianchiano P, Griffin JF, Pittman ME, Brosens LAA, Noe M, Yu J, Shindo K, Suenaga M, Neda R,  Yonesco R, Ning Y, Albores-Saavedra J, Yoshizawa N, Haradi K, Yoshizawa A, Hanada K, Yonehara S, Shimizu M, Uehera T, Samra JS, Gill AJ, Wolfgang CL, Goggins MG, Hruban R, Wood LD Genetic analyses of isolated high-grade pancreatic intraepithelial neoplasia (HG-PanIN) reveal paucity of alterations in TP53 and SMAD4 Journal of Pathology 2017;242(1):16-23

Nahm C, Mittal A, Gill AJ, Samra JS Pancreatic Rheumatoid Nodule - Case Report and Review of the Literature Pancreas 2017 46(5):e45-e47

Johns AL, McKay SH, Humphris HL, Pinese M, Chantrill LA, Mead RS, Tucker K, Andrews L, Goodwin A, Leonard CR, High HA, Nones K, Patch A-M, Merrett ND, Pavlakis N, Kassahn KS, Samra JS, Miller DK, Chang DK, Pajic M, Australian Pancreatic Genome Initiative, Pearson JV, Grimmond SM, Waddell N, Zeps N, Gill AJ, Biankin AV Lost in translation: returning germline genetic results in genome-scale cancer research Genome Medicine 2017;9(1):41

De Sousa S, McCabe MJ, Wu K, Roscioli T, Brook K, Rawling L, Scott HS, Thompson TJ, Earls P, Gill AJ, Cowley MJ, Dinger ME, McCormack AI Germline variants in familial pituitary tumour syndrome genes are common in young patients and families with additional endocrine tumours European Journal of Endocrinology 2017;176:635-644

Nahm CB, de Reuver PR, Hugh TJ, Pearson A, Gill AJ, Samra JS, Mittal A Intra-operative amylase concentration in peri-pancreatic fluid predicts pancreatic fistula after distal pancreatectomy J Gastrointestinal Surg 2017;21(6):1031-1037

Barazeghi E, Gill AJ, Sidhu S, Norlen O, Dina R, Palazzo F, Hellman P, Stalberg P, Westin G A role for TET2 in parathyroid carcinoma Endocrine Related Cancer 2017; 24:309–318

Chui J, Singh A, Gill AJ Loss of BAP1 expression is very rare in breast carcinoma Pathology 2017;49:57–560

Najdawi F, Crook A, Maidens J, McEvoy C, Fellowes A, Pickett J, Ho M, Nevell D, McIlroy K, Sheen A, Sioson L, Ahadi M, Turchini J, Clarkson A, Hogg R, Valmadre S, Gard G, Dooley SJ, Scott RJ, Fox SB, Field M, Gill AJ Lessons learnt from implementation of a Lynch syndrome screening programme for patients with gynaecological malignancy Pathology 2017;49:457-464

Dwight T, Na U, Kim E, Zhu Y, Richardson A-L, Robinson BG, Tucker KM, Gill AJ, Been DE, Clifton-Bligh RJ, Winge DR Analysis of SDHAF3 in familial and sporadic pheochromocytoma and paraganglioma BMC Cancer 2017;17:497

Flynn A, Dwight T, Benn D, Deb S, Colebatch A, Fox S, Harris J, Duncan E, Robinson B, Trainer A, Hogg A, Miller J, Yates, Gill AJ, Clifton-Bligh RJ, Hicks RJ, Tothill RW Cousins not twins: intra and inter-tumoral heterogeneity in syndromic neuroendocrine tumors Journal of Pathology 2017;242(3):273-283

Raphael BJ, Hruban RH, Aguirre AJ, Moffit RA, Yeh HH, Stewart C, Robertson AG, Cherniack AD, Gupta M, Getz G, Gabriel SB, Meyerson M, Cibulskis C, Fei SS, Hinoue T, Shen H, Laird PW, Ling S, Lu Y, Mills GB, Akbani R, Loher P, Londin ER, Rigoutsos I, Telnis AG, Gibb EA, Goldenberg A, Mezlini AM, Hoadley KA, Collisson E, Lander E, Murray BA, Hess J, Rosenberg M, Bergelson L, Zhang H, Cho J, Tiao G, Kim J, Livitz D, Leschchiner I, Reardon B, van Allen E, Kamburov A, Beroukhim R, Saksena G, Shumaker SE, Nobel MS, Heiman DI, Gehlenborg N, Kim K, Lawrence MS, Adsay VA, Peerson G, Klimstra D, Bardessy B, Leiserson MDM, Bowlby R, Kasaian K, Birol I, Mungal KL, Sadeghi S, Weinstein JN, Spellman PT, Liu Y, Amundadottir LT, Tepper J, Singhi AD, Dhir R, Paul D, Smurk T, Zhang L, Kim P, Bowen J, Frick J, Gastier-Foster JM, Gerken M, Lau K, Leraas KM, Lichtenberg TM, Ramirez NC, Renkel J, Sherman M, Wise L, Yena P, Zmuda E, Shih J, Ally A, Balasundaram M, Carlsen R, Chu A, Chuah E, Clarke A, Dhalla N, Holt RA, Jones SJM, Lee D, Ma Y, Marra MA, Mayo M, Moore RA, Mungall AJ< Schein JE, Sipahimalani P, Tam A, Thiessen N, Tse K, Wong T, Brooks D, Suman T, Balu S, Bodenheimer T, Hayes DN, Hoyle AP, Jefferys SR, Jones CD, Meng S, Mieczkowski PA, Mose LE, Perous CM, Perous AM, Roach J, Shi Y, Simons JV, Skelly T, Soloway MG, Tan D, Veluvolu U, Parker JS, Wilkerson MD, Korkut A, Senbabaoglu Y, Burch P, McWilliams R, Chaffee K, Oberg A, Zhang W, Gingras M-C, Wheeler DA, Xi L, Albert M, Bartlett J, Sekhon H, Stephen Y, Howard Z, Miller J, Breggia A, Shroff RT, Chudamani S, Liu J, Lolla L, Naresh R, Phil T, Sun Q, Wan Y, Wu Y, Smither J, Roggin K, Becker K-F, Behera M, Bennett J, Boice L, Burks E, Carlotti CG, Chabot J, da Cunha Tirapelli, DP, dos Santos JS, Dubina M, Eschbacher J, Huang M, Huelsenbeck-Dill L, Jenkins R, Karpov A, Kemp R, Lyadov V, Maithel S, Mankihas G, Montgomery E, Noushmehr H, Osunkoya A, Owonikok T, Paklin O, Potapova O, Ramalingham S, Rathmel WK, Rieger-Christ K, Saller C, Setdikova G,Shabunin A, Sica G, Su T, Sullivan T, Swanson P, Tarvin K, Tavobilov M, Thorne LB, Urbanski S, Voronina O, Wang T, Crain D, Curley E, Gardner J, Mallery D, Morris S, Paulauskis K, Penny R, Shelton C, Shelotn T, Janssen K-P, Bather O, Bahary N, Slotta-Huspenina J, Johns A, Hibshoosh H, Hwang RF, Suplveda A, Radenbaugh A, Baylin SB, Berrios M, Bootwalla MS, Holbrook A, Lai PH, Maglinte DT, Mahurkar S, Tirche TJ, van Den Berg DJ, Weisenberger DJ, Chin L, Kucherlapati R, Kucherlapati M, Pantazi A, Paerk P, Saksena G, Voet D, Lin P, Frazer S, Defreitas T, Meier S, Chin L, Kwon SY, Kim YH, Park S-J, Han S-S, Kim SH, Kim H, Furth E, Tempero M, Sander C, Biankin A, Chang A, Bailey P, Gill AJ, Kench J, Grimmond S, Johns A, Australian Pancreatic Genome Australian Pancreatic Cancer Genome Initiative (APGI), Postier R, Zuna R, Sicotte H, Demchok JA, Ferguson M, Hutter CM,Shaw KRM, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zhang J, Felau I, Zenklusen JC Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma Cancer Cell. 2017;32:185-203.

Itchins M, Chia PL, Hayes SA, Howell VM, Gill AJ, Cooper WA, John T, Mitchell P, Millward M, Clarke SJ, Solomon B, Pavlakis N Treatment of ALK-rearranged non-small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian context Asia Pac J Clin Oncol. 2017;13 Suppl 3:3-13.

Schlichtemeier S, Logaraj A, Gill AJ, Engel A Response to Bethune et al Colorectal Disease 2017;19(6):589-590

Harris NLE, Vennin C, Conway JRW, Vine KL, Pinese M, Cowley MJ, Shearer RF, Lucas MC, Herrmann D, Allam AH, Pajic M, Morton JP, Australian Pancreatic Genome Inititative, Biankin AV, Ranson M, Timpson P, Saunders DN SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer Oncogene 2017;36(30):4288-4298

Turchini J, Andrici J, Sioson L, Clarkson A, Watson N, Toon CW, Shepherd P, Ng D, Dixon-McIver A, Oei P, Gill AJ NRASQ61R mutation specific immunohistochemistry is highly specific for either NRASQ61R or KRASQ61R mutation in colorectal carcinoma Applied Immunohistochemistry and Molecular Morphology 2017; 25:475-480.

Tang C, Lindsay J, Gill AJ, Kerridge I Defibrotide Use in Vincristine-induced Hepatic Sinusoidal Obstruction Syndrome Clin Lymphoma Myeloma Leuk. 2017;17:539-541

Itchins M, Arena J, Nahm C, Rabindran J, Kim S, Gibbs E, S, Bergamin S, Chua TC, Gill AJ, Maher R, Diakos C, Wong M, Mittal A, Hruby G, Kneebone A, Pavlakis N, Samra J & Clarke S Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic ductal adenocarcinoma in a high volume referral centre Eur J Surg Oncol. 2017 Sep;43(9):1711-1717

Cole AJ, Zhu Y, Dwight Y, Yu B, Dickson K-A, Gard GB, Maidens J, Valmadre S, Gill AJ, Clifton-Bligh R, Marsh DJ  Comprehensive analyses of somatic TP53 mutation in tumors with variable mutant allele frequency Scientific Data 2017 Sep 5;4:170120

Zern NK, Clifton-Bligh R, Gill AJ, Annis A, Sidhu S, Delbridge L, Learoyd D, Robinson B, Sywak M Disease Progression in Papillary Thyroid Cancer with Biochemical Incomplete Response to Initial Therapy Ann Surg Oncol. 2017;24(9):2611-2616

Chou A, Hes O, Turchini J, Trpkov K, Gill AJ Do significant TFE3 gene rearrangements occur in succinate dehydrogenase deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution Modern Pathology 2017; 30:1507-1508

Kim S, Itchins M, Arena J, Nahm C, Pavlakis N, Clarke S, Gill A, Samra JS, Mittal A Patterns and Determinants of Recurrence for Pancreatic Ductal Adenocarcinoma after Resection JOP J Pancreas (Online) 2017 Nov 30; 18(6):458-464

Trpkov K, Abou-Ouf H, Hes O, Lopex JI, Nesi G, Comperat E, Sibony M, Osunkoya A, Zhou M, Gokden N, Leroy X, Berney D, Cunha IW, Musto ML, Thanazio D, Yilmaz A, Donnelly B, Hyndman EM, Gill AJ, McKenney J, Bismar T Eosinophilic Solid and Cystic Renal Cell Carcinoma (ESC RCC): Further Morphological and Molecular Characterization of ESC RCC as a Distinct Entity American Journal of Surgical Pathology 2017;41:1299–1308

Balachandran VP, Łuksza M,  Zhao JN, Makarov V, Moral1 JA, Remark R,

Herbst B, Askan A, Bhanot U, Senbabaoglu Y, Wells DK, Cary CIO, Grbovic-Huezo O, Attiyeh M, Medina B, Zhang J, Loo J, Saglimbeni J, Abu-Akeel M, Zappasodi R, Riaz N, Smoragiewicz M, Kelley ZL, Basturk O, Australian Pancreatic Cancer Genome Initiative, Gönen M, Levine AJ, Allen PJ, Fearon DT, Merad M, Gnjatic S, Iacobuzio-Donahue CA, Wolchok JD, DeMatteo RP, Chan TA, Greenbaum BD, Merghoub T, Leach SD Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer Nature 2017 Nov 23;551(7681):512-516

Stephenson DP, Nahm CV, Chua TC, Gill AJ, Mittal A, De Reuver PR, Samra JS Circulating and disseminated tumour cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis Oncotarget 2017;8:107223-107236

Pickett JL, Chou A, Andrici JA, Clarkson A, Sioson L, Sheen A, Reagh J, Najdawi F, Kim Y, Riley D, Maidens J, Nevell D, McIlroy K, Valmadre S, Gard G, Hogg R, Turchini J, Robertson G, Friedlander M, Gill AJ Inflammatory myofibroblastic tumors of the female genital tract are under-recognized: A low threshold for ALK immunohistochemistry is required American Journal of Surgical Pathology 2017;41:1433–1442

Chandrasegaram MD, Gill AJ, Samra J, Price T, Chen J, Fawcett J, Merrett ND. Ampullary cancer of intestinal origin and duodenal cancer - a logical clinical and therapeutic subgroup in periampullary cancer. World J Gastrointest Oncol 2017; 9: 407-415

Chua TC, Mittal A, Arena J, Sheen A, Gill AJ, Samra JS Resection margin influence survival after pancreatoduodenectomy for distal cholangiocarcinoma American Journal of Surgery 2017 Jun;213(6):1072-1076

​

​

​

​

Trpkov K, Hes O, Bonert M, Lopez JI, Bonsib SM, Nesi G, Comperat E, Sibony M, Berney DM, Martinek P, Bulimbasic S, Suster S, Songoi A, Yilmaz A, Higgins JP, Zhou M, Gill AJ, Przbycin CG, Magi-Galluzzi C, McKenney JK Eosinophilic, Solid, And Cystic Renal Cell Carcinoma (ESC RCC): Clinicopathologic Study of 16 Unique, Sporadic Neoplasms Occurring in Women American Journal of Surgical Pathology 2016; 40:60-71

Andrici J,* Goeeppert B,* Sioson L, Clarkosn A, Renner M, Stenzinger A, Tayao M, Watson N, Farzin M, Toon CW, Smith RC, Mittal A, Samra JS, Hugh TH, Chou A, Lawlor RT, Weichert W, Shirmacher P, Sperandio N, Ruzzenente A, Scarpa A, Gill AJ Loss of BAP1 expression occurs frequently in intrahepatic cholangiocarcinoma Medicine 2016 Jan;95(2):e2491

Gifford GK, Gill AJ, Stevenson W Molecular subtyping of diffuse large B-cell lymphoma; update on biology, diagnosis and emerging platforms for practicing pathologists Pathology January 2016; 48:5-16

Charles KA, Harris BD, Haddad CR, Clarke SJ, Guminski A, Stevens M, Dodds T, Gill AJ, Back M, Veivers D, Eade T Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients BMC Cancer. 2016 Feb 18;16(1):124

Chua T, de Ruver PR, Staerkle RF, Neale ML, Arena J, Mittal A, Shanbhag ST, Gill AJ, Samra JS.  Transverse closure of mesenterico-portal vein after vein resection in pancreaticoduodenectomy European Journal of Surgical Oncology 2016 Feb;42(2):211-8.

Chua TC, Yang TX, Gill AJ, Samra JS Systematic Review and Meta-Analysis of the Safety and Efficacy Enucleation versus Standardized Resection for Small Pancreatic Lesions Annals of Surgical Oncology 2016 Feb;23(2):592-9

Annamalai AK, Sampathkumar K, Kane S, Shetty NS, Kulkarni S, Rangarajan V, Purandare N, Pai PS, Mahuvakar AD, Shanthi R, Suriyakumar G, Puri V, Subramaniam A, Gopalakrishnan C, Chelian M, Srinivasan KG, Gill AJ, Gurnell M, Clifton-Bligh R Needle(s) in the Haystack – Synchronous Multifocal Tumor Induced Osteomalacia Journal of Clinical Endocrinology and Metabolism 2016;101:390-3

Gringas M-C, Covington KR, Chang DK, Donehower LA, Gill AJ, Ittmann MM, Creighton CJ, Johns AL, Shinbrot E, Dewal N, Fisher WE, Australian Pancreatic Genome Iniativie, Pilarsky C, Grutzmann R, Overman MJ, Jamieson NB, vn Buren G, Drummond J, Walker K, Hampton OA, Xi L, Muznyl DM, Doddapaneni H, Lee SL, Bellair M, Hu J, Han Y, Din HH, Dahdouli M, Samra JS, Bailer P, Waddell N, Pearson JV, Harliwong I, Wang H, Aust D, Oien KA, Hruban RH, Hodges SE, McElhany A, Duthie FR, Grimmond SM, Biankin AV, Wheeler DA, Gibbs RA Ampullary cancers harbor a novel ELF3 tumor suppressor and exhibit frequent WNT dysregulation Cell Reports 2016;14:907-19

Andrici J, Farzin M, Sioson L, Clarkson A, Watson N, Toon CW, Gill AJ Mismatch repair deficiency as a prognostic factor in mucinous colorectal cancer Modern Pathology 2016; 29:266-274

Bailey P, Chang DK, Nones K, Johns AL, Patch A-M, Gringas M-C, Miller D, Christ A, Bruxner T, Nourse C, Muraugh C, Harliwong I, Idrisoglu S, Manning S, Nourbakhsh E, Wani S, Quinn M, Fink L, Holmes O, Anderson M, Kazakoff S, Leonard C, Newell F, Waddell N, Wood S, Xu C, Wilson PJ, Cloonan N, Kassahn KS, Taylor D, Quek K, Robertson A, Wu J, Pinese M, Cowley MJ, Jones MD, Colvin EK, Nagrial AM, Humphrey ES, Chantrill LA, Mawson A, Humphris J, Chou A, Pajic M, Scarlett CJ, Pinho AV, Rooman I, Samra JS, Kench JG, Lovell JA, Merrett ND, Toon C, Epari K, Nguyen NQ, Barbour A, Zeps N, Jamieson NB, Graham JS, Duthie F, Oien K, Hair J, Grutzmann R, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Wolfgang CL, Morgan RA, Lawlor RT, Corbo V, Bassi C, Falconi M, Zamboni G, Tortora G, Mukhopadyhyay D, Petersen GM, Australian Pancreatic Genome Initiative, Eshlemen JR, Pilarsky C, Morten OJP, Sansom OJ, Scarpa A, Musgrove EA, Sutherland RL, Wheeler DA, Gill AJ, Gibbs RA, Pearson JV, Waddell N, Biankin AV, Grimmond SM Integrative genomic analysis of pancreatic cancer identifies subtypes with distinct histopathological characteristics Nature 2016;531(7592):47-52

Andrici J, Jung J, Sheen A, D’Urso L, Sioson L, Pickett J, Parkhill TR, Verdonk B, Wardell KL, Singh A, Clarkson A, Watson N, Toon CW, Gill AJ Loss of BAP1 expression is very rare in peritoneal and gynaecological serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma Human Pathology 2016;51:9-15.

Reagh JJH, Eckstein RP, Selinger CI, Evans J, O’Toole SA, Gill AJ Liposarcoma masquerading as an inflammatory pseudotumor: a case report Journal of Medical Case Reports 2016;10:64 DOI: 10.1186/s13256-016-0858-y

Bogun Y, Sioson L, Watson N, Pickett J, Gill AJ False positive EGFR mutation specific immunohistochemistry in Her2 positive breast cancers - a potential diagnostic pitfall Applied Immunohistochemistry and  Molecular  Morphology 2016;24(3):227

Tayao M,# Andrici J,# Farzin M, Clarkson A, Sioson L, Watson N, Chua TC, Sztynda T, Samra JS,* Gill AJ* Loss of BAP1 expression is very rare in pancreatic ductal adenocarcinoma PlosOne 2016 Mar 16;11(3):e0150338

Flynn A, Dwight T, Harris J, Benn D, Zhou L, Hogg A, Catchpoole D, James P, Duncan EL, Trainer A, Gill AJ, Clifton-Bligh R, Hicks R, Tothill RW Pheo-type: a diagnostic gene-expression assay for the classification of pheochromocytoma and paraganglioma Journal of Clinical Endocrinology and Metabolism, 2016;101(3):1034-43

Julovi SM, Xue A, Thanh LE TN, Gill AJ, Bulanadi JC, Patel M, Waddington LJ, Rye KA, Moghaddam MJ, Smith RC Apolipoprotein A-II Plus Lipid Emulsion Enhance Cell Growth via SR-B1 and Target Pancreatic Cancer In Vitro and In Vivo PLoS One 2016 Mar 22;11(3):e0151475.

De Reuver P, Mehta S, Gill P, Andrici J, D’Urso L, Clarkson A, Mittal A, Hugh TJ, Samra JS, Gill AJ Immunoregulatory Forkhead Box Protein P3-positive lymphocytes are associated with overall survival in Pancreatic Neuroendocrine Tumors Journal of the American College of Surgeons 2016;222(3):281-7

Papathomas T, Pucci E, Giordano TJ, Lu H, Duregon E, Volante M, Papotti M, Lloyd RV, Tischler A, van Nedervenn FH, Nose V, Erickson L, Mete O, Asa SL, Turchini J, Gill AJ, Matias-Cuiu X, Skordilis K, Stephenson TJ, Tissier F, Feelders RA, Smid M, Nigg A, Korpershoek E, van der Spek PJ, Dinjens W, Stubbs A, de Krijger RR An International Ki67 Reproducibility Study in Adrenal Cortical Carcinoma American Journal of Surgical Pathology Volume 40(4), April 2016, p 569–576

Harrison WJ,* Andrici J,* Maclean F, Madadi-Ghahan R, Farzin M, Sioson L, Toon CW, Clarkson A, Watson N, Pickett J, Field M, Crook A, Tucker K, Goodwin A, Anderson L, Srinivasan B, Grossman P, Martinek P, Ondic O, Hes O, Trpkov K, Clifton-Bligh RJ, Dwight T, Gill AJ Fumarate hydratase deficient uterine leiomyomas occur in both the syndromic and sporadic settings American Journal of Surgical Pathology 2016; 40:599–607

Gallinger B, Druker H, Gill AJ, Wasserman JD, Kim RH The adrenal gland: an evolution of the roles of genetic counsellors and medical geneticists in endocrine cancers Diagnostic Histopathology 2016;22:108–122

Barazeghi E, Gill AJ, Sidhu S, Norlen O, Dina R, Palazzo F, Hellman P, Stalberg P, Westin W 5-Hydroxymethylcytosine Discriminates between Parathyroid Adenoma and Carcinoma Clinical Epigenetics 2016;8:31

Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G, Morozova O, Akbani R, Shih J, Hoadley KA, Choueiri TK, Waldman J, Mete O, Robertson AG, Raphael BJ, Meyerson M, Demeuere MJ, Beuschlein F, Gill AJ, Sidhu SB, Latronico AC, Fragoso MC, Cope LM, Kebebew E, Habra MA, Whitsett TG, Bussey KJ, Rainey WE, Asa SL, Bertherat J, Fassnacht M, Wheeler DA, The Cancer Genome Atlas Research Network, Hammer GD,* Giordano TJ,* Verhaak RGW* Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma Cancer Cell 2016; 29:723–736

Cole AJ, Dwight T, Gill AJ, Dickson K-A, Zhu Y, Clarkson A, Gard GB, Maidens J, Valmadre S, Clifton-Bligh R and Marsh DJ Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing Scientific Reports May 18; 6: 26191

Friedman K, Brodksy AS, Lu S, Wood S, Gill AJ, Lombardo K Yang D, Resnick MB A distinct morphology reveals a distinctive immunoregulatory microenvironment Modern Pathology 2016;29:528-41

Glastras SJ, Chen H, McGrath R, Zaky AA, Gill AJ, Pollock CA, Saad S Effect of GLP-1 receptor activation on offspring kidney health in a rat model of maternal obesity Scientific Reports 2016; 6: 23525.

Chua TC, Gill P, Gill AJ, Samra JS Ileocecal Intussusception Caused by an Appendiceal Neoplasm Journal of Gastrointestinal Surgery 2016 Apr;20(4):867-8

Chua TC, Petrushnko W, Mittal A, Gill AJ, Samra JS Pancreatic Metastasectomy – An Analysis of Survival Outcomes and Prognostic Factors Journal of Gastrointestinal Surgery 2016 Jun;20(6):1188-93

Fraser S, Go C, Aniss A, Sidhu S, Delbridge L, Learoyd D, Clifton-Bligh R, Tacon L, Tsang V, Robinson B, Gill AJ, Sywak M BRAF(V600E) Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer World J Surg. 2016;40:1618-24

Andrici J, Parkhill TR, Jung J, Wardell KL, Verdonk B, Singh A, Sioson L, Clarkson A, Watson N, Sheen A, Farzin M, Toon CW, Gill AJ Loss of expression of BAP1 is very rare in non-small cell lung carcinoma  Pathology 2016 48:336–340

Andrici J, Farzin M, Clarkson A, Sioson L, Sheen A, Watson N, Toon CE, Koleth M, Stevenson W, Gill AJ Mutation specific immunohistochemistry is highly specific for the presence of calreticulin mutations in myeloproliferative neoplasms Pathology 2016; 48:319–324

Huang C, Zhan Y, Kelly DJ, Tan CYR, Gill AJ, Cheng D, Braet F, Park J-S, Sue CM, Pollock CA, Chen X-M Thioredoxin interacting protein (TXNIP) regulates tubular autophagy and mitophagy in diabetic nephropathy through the mTOR signalling pathway Scientific Reports 2016;6:29196.

Wong YP, Sharifah NA, Tan GC, Gill AJ, Ali SZ Intrathyroidal Oxyphilic Parathyroid Carcinoma: A Potential Diagnostic Caveat in Cytology? Diagnostic Cytopathology 2016;44(8):688-92

Trpkov K, Hess O, Agaimy A, Bonert M, Martinek P, Magi-Galluzzi C, Kristiansen G, Lüders C, Nesi G, Comperat E, Sibony M, Berney DM, Mehra R, Brimo F, Hartman A, Husain A, Frizzell N, Hills K, Maclean F, Srinivasan B, Gill AJ Fumarate Hydratase-deficient Renal Cell Carcinoma is Strongly Correlated with Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome American Journal of Surgical Pathology 2016;40:865–875

Safran H, Resnick MB, Magray S, Wheeler M, Jackson CL, Lombardo KA, Kim K-M, Gill AJ, Wang K, Gowen K, Sun J, Miller VA, Stephens PJ, Ali SM, Ross JS, Yakirevich E Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target Clinical Cancer Research 2016;22:3831-40

Wang J, Andrici J, Sioson L, Clarkson A, Sheen A, Farzin M, Toon CW, Turchini J, Gill AJ Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation and mismatch repair deficiency Human Pathology 2016;55:83–90

Bullock M, Ran Y, O’Neill C, Gill AJ, Aniss A, Sywak M, Sidhu S, Delbridge L, Learoyd D, de Vathaire F, Robisnon BG, Clifton-Bligh RJ TERT Promoter Mutations Are a Major Indicator of Recurrence and Death due to Papillary Thyroid Carcinomas Clinical Endocrinology 2016;85:283-90

Ahadi M, Andrici J, Sioson L, Sheen A, Clarkson A, Gill AJ Loss of Hes1 expression is associated with poor prognosis in colorectal adenocarcinoma Human Pathology 2016; 57:91-97

Schlichtemeier SM, Pang TC, Williams NE, Gill AJ, Smith RC, Samra JS, Lam VW, Hollands M, Richardson AJ, Pleass HC, Nozawa S, Albania M, Hugh TJ A pre-operative clinical model to predict microvascular invasion and long-term outcome after resection of hepatocellular cancer: The Australian experience Eur J Surg Oncol. 2016;42:1576-83

Smith SC, Trpkov K, Chen Y-B, Mehra R, Siohi D, Ohe C, Cani AK, Hovelson DH, Omata K, McHugh HB, Jochum W, Colecchia M, Amin M, Divatia MK, Hes O, Menon S, da Cunha IW, Tripodi S, Brimo F, Gill AJ, Osunkoya AO, Magi-Galluzzi C, Sibony M, Williamson SR, Nesi G, Picken MM, Maclean F, Agaimy A, Cheng L, Epstein JI, Reuter VE, Tickoo SK, Tomlins SA, Amin  MB Tubulocystic Carcinoma of the Kidney with Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-Deficient Renal Cell Carcinoma American Journal of Surgical Pathology 2016; 40:1457-1472

Donaldson L, Gill AJ, Hibbert M The utility of surgical lung biopsy in critically ill patients with diffuse pulmonary infiltrates: A retrospective review Internal Medicine Journal 2016;46:1306-1310

Pinho AV, Mawson A, Gill AJ, Arshi M, Warmerdam M, Giry-Laterriere M, Eling N, Liel T, Kuster E, Camargo SR, Biankin AV, Wu J, Rooman I Sirtuin1 stimulates the proliferation and the expression of glycolysis genes of pancreatic neoplastic lesions Oncotarget 2016;7:74768-74778

Beadnall HN, Gill AJ, Rimington S, Barnett MH Virus-related Merkel Cell Carcinoma Complicating Fingolimod Treatment for Multiple Sclerosis Neurology 2016;87:2595-2597

Kim E, Wright MJ, Sioson L, Navos T, Gill AJ, Benn DE, White C, Dwight T, Clifton-Bligh RJ Utility of the succinate:fumarate ratio for assessing SDH dysfunction in different tumor types Molecular Genetics and Metabolism Reports 2016;10:45-49

Dickson K-A, Cole AJ, Gill AJ, Clarkson A, Gard GB, Chou A, KennedyCJ, Henderson BR, Australian Ovarian Cancer Study (AOCS), Fereday S, Traficante N, Alson K, Bowtell DD, DeFazio A, Clifton-Bligh R, Marsh DJ The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancer Human Molecular Genetics 2016;25(24):5460-5471

Raut A, Andrici J, Severino A, Gill AJ The death of the hospital autopsy in Australia? The hospital autopsy rate is declining dramatically Pathology 2016;48:645-649

​

​

​

Clugston E, Gill AC, Graf N, Bonar F, Gill AJ Use of immunohistochemistry for SSTR2A to support a diagnosis of phosphaturic mesenchymal Pathology 2015; 47:173-5

AR Glover, JT Zhao, JC Ip, JC Lee, BG Robinson, AJ Gill, PSH Soon, SB Sidhu Long noncoding RNA profiles of adrenocortical cancer can be used to predict recurrence Endocrine Related Cancer 2015 Feb;22(1):99-109

T Pang, A Kaufman, J Choi, A Gill, M Drummond, T Hugh, J Samra Peroxisome proliferator-activated receptor-α staining is associated with worse outcome in colorectal liver metastases Molecular and Clinical Oncology 2015; 3:308-316

Houang M, Toon CW, Clarkson A, Sioson L, de Silva K, Watson N, Singh NR, Chou A, Gill AJ ALK and ROS1 overexpression is very rare in colorectal adenocarcinoma Applied Immunohistochemistry and Molecular Morphology 2015; 23:134-8

Gundara JS, Zhao J, Gill AJ, Lee JC, Delbridge L, Robinson BG, McLean C, Serpell J, Sidhu SB Noncoding RNA blockade of autophagy is therapeutic in medullary thyroid cancer. Cancer Med. 2015;4(2):174-82

Waddell N, Pajic M, Patch A-M, Chang DK, Kassahn KS, Bailey P, Johns AL, Miller D, Nones K, Quek K, Quinn M, Robertson A, Fudlullah M, Bruxner T, Christ An Harliwong I, Idrisoglu S, Manning S, Nourse C, Nourbakhsh E, Wani S, Wilson PJ, Markham E, Cloonan N, Anderson M, Fink L, Holmes O, Kazakoff S, Conrad L, Newell F, Song S, Taylor D, Waddell N, Wood S, Xu C, Wu J, Pinese M, Cowley MJ, Jones MD, Colvin EK, Nagrial AM, Humphrey ES, Chantrill LA, Mawson A, Humphris J, Chou A, Scarlett CJ, Pinho AV, Rooman I, Samra JS, Kench JG, Lovell JA, Merrett ND, Toon T, Epari K, Nguyen NQ, Barbour A, Zeps N, Jamieson NB, Graham JS, Grützmann R, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Wolfgang CL, Morgan RA, Lawlor RT, Corbo V, Bassi C, Falconi M, Zamboni G, Tortora G, Tempero MA, Australian Pancreatic Cancer Genome Initiatie, Gill AJ, Eshlemen JR, Pilarsky C, Scarpa A, Musgrove EA, Sutherland RL, Pearson JV, Biankin AV, Grimmond SM Whole Genomes Redefine the Mutational Landscape of Pancreatic Cancer Nature 2015; 518:495–501

Elston MS, Meyer-Rochow GY, Conaglen HM, Clarkson A, Clifton-Bligh RJ, Conaglen JV, Gill AJ Increased SSTR2A and SSTR3 expression in SDH deficient pheochromocytomas and paragangliomas Human Pathology 2015;46(3):390-6

Ip JC, Pang TC, Glover AR, Soon P, Zhao JT, Clarke S, Robinson BG, Gill AJ, Sidhu SB  Immunohistochemical Validation of Overexpressed Genes Identified by Global Expression Microarrays in Adrenocortical Carcinoma Reveals Potential Predictive and Prognostic Biomarkers The Oncologist 2015; 20(3):247-56

Ip JC, Pang TC, Pon CK, Zhao JT, Sywak MS, Gill AJ, Soon PS, Sidhu SB.  Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism ANZ J Surgery October 2015,85(4):279-283

Gundara JS, Gill AJ, Glover A, Benson K, Clifton-Bligh R, Roxburgh S, Sywak M Recurrent Hyperaldosteronism after Adrenalectomy: An Indication for Careful Radiologic and Histologic Re-evaluation ANZ J Surgery 2015;85(4):289-90

Chou A, Fraser S, Toon CW, Clarkson A, Sioson L, Farzin M, Cussigh C, Aniss A, O’Neill C, Watson N, Clifton-Bligh RH, Learoyd DL, Robinson BG, Selinger CI, Delbridge LW, Sidhu SB, O’Toole SA, Sywak M, Gill AJ A Detailed Clinicopathological Study of ALK Translocated Papillary Thyroid Carcinoma American Journal of Surgical Pathology 2015;39(5):652–659

Flynn A, Benn D, Clifton-Bligh R, Robinson B, Trainer AH, James P, Hogg A, Waldeck K, Joshy G, Li J, Fox SB, Gill AJ, McArthur G, Hicks RJ, Tothill RW The genomic landscape of phaeochromocytoma  The Journal of Pathology 2015;236(1):78-89.

Chua T, Gill AJ, Samra JS Clinical Challenge and Image in GI - An Unusual Cause of Torrential Lower Gastrointestinal Haemorrhage Gastroenterology 2015 May;148(5):e10-11

Pantaleo MA,  Lolli C, Nannini M,  Astolfi A,  Indio V, Saponara M,  Urbini M,  La Rovere S,  Gill AJ,  Goldstein D,  Ceccarelli C,  Santini D,  Rossi G,  Fiorentino M,  Di Scioscio V,  Fusaroli P, Mandrioli A,  Gatto L, Catena F, Basso U,  Ercolani G, Pinna AD, Biasco G  Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations Genet Med. 2015 May;17(5):391-5.

Chantrill LA, Nagrial AM, Watson C, Johns AL, Martyn-Smith M, Simpson S, Mead S, Jones MD, Samra JS, Gill AJ, Watson N, Chin VT, Humphris JL, Chou A, Brown B, Morey A, Pajic M, Grimmond SM, Chang DK, Thomas D, Sebastian L, Sjoquist K, Yip S, Pavlakis N, Asghari R, Harvey S, Grimison P, Simes J, Biankin AV Precision medicine for advanced pancreas cancer: the individualized molecular pancreatic cancer therapy (IMPaCT) trial Clinical Cancer Research 2015; 21:2029-37

Farzin M, Toon CW, Clarkson A, Sioson L, Watson N, Andrici J, Gill AJ Loss of expression of BAP1 predicts longer survival in mesothelioma Pathology 2015; 47:302-307

Papathomas T, Oudijk L, Persu A, Gill A, van Nederveen F, Tischler A, Tissier F, Volante M, Matias-Guiu X, Smid M, Favier J, Rapizzi E, Libe R, Currás-Freixes M, Aydin S, Huynh T, Lichtenauer U, van Berkel A, Canu L, Domingues R, Clifton-Bligh R, Bialas M, Vikkula M, Baretton G, Papotti M, Nesi G, Badoual C, Pacak K, Eisenhofer G, Timmers H, Beuschlein F, Bertherat J, Mannelli M, Robledo M, Gimenez-Roqueplo A-P, Dinjens W, Korpershoek E, de krijger R SDHB/SDHA Immunohistochemistry in Pheochromocytomas and Paragangliomas: A Multicenter Interobserver Variation Analysis using Virtual Microscopy: A Multinational Study of the European Network for the Study of Adrenal Tumours (ENS@T) Modern Pathology 2015;28:807-821

Norlen O, Charlton A, Henwood T, Shun A, Sarkis LM, Gill AJ,  Delbridge LW Risk of malignancy for each Bethesda class in pediatric thyroid nodules Journal of Pediatric Surgery 2015;50(7):1147-9

de Reuver PR, Mittal A, Neale M, Gill AJ, Samra JS Extended pancreaticoduodenectomy as defined by the International Study Group for Pancreatic Surgery is associated with worse survival but not with increased morbidity Surgery 2015; 158(1):183-90

Cheng JY, Gill AJ, Kumar SK Granulosa Cell Tumour of the Adrenal Pathology 2015; 47:487-9

Mittal A, de Reuver PR, Shanbhag S, Staerkle RF, Neale M, Thoo C, Hugh TJ, Gill AJ, Samra JS Distal pancreatectomy, splenectomy, and celiac axis resection (DPS-CAR): Common hepatic arterial stump pressure should determine the need for arterial reconstruction Surgery 2015; 157(4):811-7

Chan D, Clarke S, Gill AJ, Chantrill L, Samra J, Li BT, Barnes T, Nahar K, Pavlakis N Pathogenic PALB2 mutation in metastatic pancreatic neuroendocrine tumour: A case report Mol Clin Onc, 2015;3:817-819.

Martínek P, Grossmann P, Hes O, Bouda J, Eret V, Frizzell N, Gill AJ, Ondič O Genetic testing of leiomyoma tissue in women younger than 30 years old might provide an effective screening approach for the hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC) Virchows Archive 2015;467:185-91

Xue A, Julovi S, Hugh TJ, Samra JS, Wong MH, Gill AJ, Smith RC A patient-derived subrenal capsule xenograft model can predict response to adjuvant therapy for cancers in the head of the pancreas Pancreatology 2015;15(4):397-404.

Howson P, Kruijff S, Aniss A, Pennington T, Gill AJ, Dodds T, Delbridge LW, Sidhu SB, Sywak MS Oxyphil Cell Parathyroid Adenomas Causing Primary Hyperparathyroidism: a Clinico-Pathological Correlation Endocrine Pathology 2015 Sep;26(3):250-4.

Knox RD, Luey N, Sioson L, Kedziora A, Clarkson A, Watson N, Toon CW, Cussigh C, Pincott S, Pillinger S, Salama Y, Evans J, Percy J, Schitzler M, Engel A, Gill AJ Medullary colorectal carcinoma revisited – a clinical and pathological study of 102 cases Annals of Surgical Oncology 2015; 22:2988-2996

Gundara J, Gill AJ,* Samra J* Efficacy of primary tumour volume as a predictor of survival compared with size alone in pancreatic ductal adenocarcinoma Oncology Letters 2015;10(2):744-748.

Dodds T, D’Urso L, Gill AJ BRAFV600E mutation is rare in clear cell ovarian carcinoma, but could potentially be identified with mutation specific immunohistochemistry Pathology 2015; 47:591–593

J Collins J, Gill AJ, Bell C,  Kellow J Gastroenterology: Rare cause of upper gastrointestinal bleeding Journal of Gastroenterology and Hepatology 2015; 30:445

Chin VT, Nagrial AM, Chou A, Biankin AV, Gill AJ, Timpson P, Pajic M Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunities. Expert Rev Mol Med. 2015 Oct 28;17:e17.

Luchini C, Veronese N, Solmi M, Cho H, Kim J-H, Chou A, Gill AJ, Faraj SF, Chaux A, Netto GH, Nakayama K, Kyo S, Lee S-Y, Kim D-W, Yousef GM, Scorilas A, Nelson GS, Kobell M, Kalloger SE, SChaeefer DF, Yan H-B, Liul F, Yokoyama Y, Zhang X, Pang D, Sergi G, Manzato E, Capelli P, Scarpa A, Correll CU Prognostic role and implications of mutational status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis Oncotarget 2015;6(36):39088-97.

Selinger CI,  Cooper WA, Lum T, McNeil C, Morey A, Waring P, Amanuel B, Millward M, Peverall J, VanVliet B, Christie M, Tran Y, Diakos C, Pavlakis N, Gill AJ, O’Toole SA Equivocal ALK FISH cases may benefit from ancillary ALK FISH probe testing Histopathology 2015;67(5):654-63

Andrici J, Sheen A, Sioson L, Wardell K, Clarkson A, Watson N, Ahadi MS, Farzin M, Toon CW, Gill AJ  Loss of expression of BAP1 is a useful adjunct which strongly supports the diagnosis of mesothelioma in effusion cytology Modern Pathology 2015; 28:1360–1368

Glover A, Zhao JT, Gill AJ, Weiss J, Mugridge N, Kim E, Feeney A, Ip J, Reid G, Clarke S, Soon P, Robinson B, Brahmbhatt H, MacDiarmid J, Sidhu S MicroRNA-7 as a Tumor Suppressor and Novel Therapeutic for Adrenocortical Carcinoma Oncotarget 2015;6(34):36675-88.

Meytal S, de Reuver P, Gill P, Andrici J, D’Urso L, Mittal A, Pavlakis N, Clarke S, Samra JS, Gill AJ Somatostatin receptor SSTR-2a expression is a stronger predictor for survival than Ki-67 in Pancreatic Neuroendocrine Tumours Medicine 2015 Oct;94(40):e1281.

Chandrasegaram MD, Goldstein D, Simes J, Gebski V, Kench JG, Gill AJ, Samra JS, Merrett ND, Richardson AJ, Barbour AP A Meta-analysis of radical resection rates and margin assessment in pancreatic cancer British Journal of Surgery 2015; 102: 1459–1472

Vonhoff CR, Lochhead A, Koustais S, Watson N, Andrici J, Brewer J, Gill AJ Differences in the pathological diagnosis and repeat craniotomy rates in cerebral tumors undergoing biopsy or resection in an urban versus regional Medicine 2015;94(47):e2131

Wong SQ, Waldeck K, Vergaral IA, Schröder J, Madore J, Wilmott JS, Colebatch AJ, De Paoli-Iseppi R, Lil J, Lupat R, Semplel T, Arnaul GM, Fellowes A, Leonard H, Hruby G, Mann GJ, Thompson JF, Cullinanel C, Johnston M, Shackleton M, Sandhu S, Bowtell DDL, Johnston RW, Fox SF, McArthur GA, Papenfuss AT, Scolyer RA, Gill AJ, Hicks RJ, Tothill RW UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas Cancer Research 2015;75:5228-34

​

​

​

Farzin M, Toon CW, Clarkson A, Sioson L, Gill AJ BRAF V600E mutation specific immunohistochemistry with clone VE1 is not reliable in pituitary adenomas Pathology 2014; 46:79-80

Gill AJ Understanding the genetic basis of parathyroid carcinoma Endocrine Pathology 2014 25:30–34

Chen JA, Gundara JS, Haddad R, Shiavone V, Meldrum C, Samra JS, Gill AJ, Hugh TJ Clinicopathologic and molecular aspects of foregut gastrointestinal stromal tumours ANZ Journal of Surgery 2014;84(1-2):52-8

Toon CW, Chou A, Clarkson A, DeSilver K, Houang M, Chan JCY, Sioson L, Jankova L, Gill AJ Immunohistochemistry for myc predicts survival in colorectal cancer PLoS ONE 2014; 9(2): e87456. doi:10.1371/journal.pone.0087456

Paik JY, Toon CW, Benn DE, High H, Hasovits C, Pavlakis N, Clifton-Bligh RJ, Gill AJ Renal carcinoma associated with succinate dehydrogenase B (SDHB) mutation:

A new and unique subtype of renal carcinoma Journal of Clinical Oncology 2014; 32(6):pp10-e13

Nagrial AM, Chang DK, Nguyen NQ, Johns AL, Chantrill LA, Humphris JL, Chin VT, Samra JS, Gill AJ, Pajic M, Australian Pancreatic Genome Initiative, Pinese M, Colvin EK, Scarlett CJ, Chou A, Kench JG, Sutherland RL, Horvarth LG, Biankin AV Adjuvant Chemotherapy in Elderly Patients with Pancreatic Cancer British Journal of Cancer 2014; 110(2):313-319

Krujiff S, Sidhu SB, Sywak MS, Gill AJ,* Delbridge LW* (*equal senior authors) Negative parafibromin staining predicts malignant behaviour in atypical parathyroid adenomas Annals of Surgical Oncology 2014; 21(2):426-433

Huang C, Shen S Ma W, Gill AJ, Pollock CA, Chen X-M KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis. Nephrology Dialysis Transplantation 2014; 29(2):313-324

Krujic S, Petersena JF, Chen P, Aniss AM, Clifton-Bligh RJ, Sidhu SB, Delbridge LW, Gill AJ, Learoyd D, Sywak MS Patterns of structural recurrence in papillary thyroid cancer World Journal of Surgery 2014; 38(3):653-659

Gill AJ, Toon CW, Clarkson A, Sioson L, Chou A, Winship I, Robinson BG, Benn DE, Clifton-Bligh RJ, Dwight T Succinate dehydrogenase deficiency is rare in pituitary adenomas American Journal of Surgical Pathology 2014;38:560–566

Pang TCY, Wilson O, Argueta MA, Hugh TH, Chou A, Samra JS, Gill AJ Frozen section of the pancreatic neck margin in pancreatoduodenectomy for pancreatic adenocarcinoma is of limited utility Pathology 2014; 46(3):188-192

Gundara J, Zhao J, Gill AJ, Clifton-Bligh R, Robinson BG, Delbrdige L, Sidhu SB Nodal metastasis miRNA expression correlates with the primary tumour in MTC ANZ Journal of Surgery 2014; 84:235-9.

Tsang VHM, Dwight T, Benn DE, Meyer-Rochow GY, Gill AJ, Sywak M, Sidhu S, Veivers D, Sue C, Robinson BG, Clifton-Bligh RJ, Parker N Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas and gastrointestinal stromal tumours Endocrine Related Cancer 2014;21:415-26.

Toon CW, Chou A, DeSilva K, Chan J, Patterson J, Clarkson A, Sioson L, Jankova L, Gill AJ BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer Modern Pathology 2014; 27:644–650

Wang F, Gill AJ, Neale M, Puttswamy V, Gananadha S, Pavlakis N, Clarke SJ, Hugh TJ, Samra JS Adverse tumour biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma Annals Surgical Oncology 2014; 21:1937-47

Johns AL, Miller DK, Simpson SH, Gill AJ, Kasshan KS, Humphris JL, Samra JS, Tucker K, Andrews L, Chang DK, Waddell N, Pajic M, Australian Pancreatic Cancer Genome Initiative, Pearson JV, Grimmond SM, Biankin AV, Zeps N Returning individual research results for genome sequences of pancreatic cancer Genome Medicine 2014; 6(5):42 

Al-Ejeh F, Pajic M, Shi W, Kalimutho M, Miranda M, Nagrial AM, Chou A, Biankin AV, Grimmond SM; Australian Pancreatic Cancer Genome Initiative, Brown MP, Khanna KK. Gemcitabine and CHK1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal Adenocarcinoma Clin Cancer Res. 2014; 20:3187-97

Toon C, Paik J, Hasovits C, Chou A, Field M, Hugh TJ, Pavlakis N, Gill AJ Skin rash, a kidney mass and a family mystery dating back to World War II Medical Journal of Australia 2014;201(1):58-60

Alvarado-Bachmann R, Smith A, Gundara JS, Kuo SC, Gill AJ, Samra JS, Hugh TJ The incidence of mismatch repair gene defects in colorectal liver metastases. Molecular Medicine Reports 2014;10(2):1003-6

Nones K, Waddell N, Song S, Patch A-M, Miller D, Johns A, Wu J, Kassahn K, Wood D, Bailey P, Fink L,  Manning S, Christ A, Nourse C, Kazakoff S, Taylor D, Leonard C, Chang D, Jones M, Thomas M, Watson C, Pinese M, Cowley M, Rooman I, Pajic M, Butturini G, Malpaga A, Corbo V, Crippa S, Falconi M, Zamboni G, Castelli P, APGI, Lawlor R, Gill AJ, Scarpa A, Pearson J, Biankin A, Grimmond S Genome-wide DNA methylation patterns inpancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling International Journal of Cancer 2014;135(5):1110-8

Quek K, Nones K, Patch AM, Fink JL, Newell F, Cloonan N, Miller D, Fadlullah MZ, Kassahn K, Christ AN, Bruxner TJ, Manning S, Harliwong I, Idrisoglu S, Nourse C, Nourbakhsh E, Wani S, Steptoe A, Anderson M, Holmes O, Leonard C, Taylor D, Wood S, Xu Q Australian Pancreatic Cancer Genome Initiative, Wilson P, Biankin AV, Pearson JV, Waddell N, Grimmond SM A workflow to increase verification rate of chromosomal structural rearrangements using high-throughput next-generation sequencing Biotechniques. 2014 Jul 1;57(1):31-8.

Houang M, Toon CW, Clarkson A, Sioson L, Watson N, Farzin M, Selinger CI, Chou A, Morey AL, Cooper WA, O’Toole SA, Gill AJ Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer Pathology 2014; 46:383-388

Chou A, Toon CW, Clarkson A, Sioson L, Houang M, Watson N, DeSilva K, Gill AJ Loss of ARID1A expression in colorectal carcinoma is strongly associated with mismatch repair deficiency Human Pathology 2014; 45(8):1679-1703

Al-Idat Um Chen H, Chan YL, Amgad S, Wong M-G, Gill AJ, Pollock C, Saad S The impact of maternal cigarette smoke exposure in a rodent model on renal development in the offspring PLoS One The Impact of Maternal Cigarette Smoke Exposure in a Rodent Model on Renal Development in the Offspring. PLoS One. 2014 Jul 24;9(7):e103443

Kozor R, Pollock C, Gill AJ, Bhindil R, Figtree GA Fabry disease deposition mimicking a cardiac tumour and precipitating heart block European Heart Journal - Cardiovascular Imaging 2014 Aug;15(8):869

Baker LJ, Gill AJ, Chan C, Lin BPC, Crawford BA Parasitic Thyroid Nodules: Cancer or Not? Endocrinology, Diabetes and Metabolism Case Reports 2014:140027. doi: 10.1530/EDM-14-0027

Wong MH, Xue A, Julovi SM, Pavlakis N, Samra JS, Hugh TJ, Gill AJ, Peters L, Baxter RC, Smith RC Co-targeting of epidermal growth factor receptor (EGFR) and PI3K overcomes PI3K/Akt oncogenic dependence in pancreatic ductal adenocarcinoma Clinical Cancer Research 2014 Aug 1;20(15):4047-58

Morran DC, Wu J, Jamieson NB, Mrowinska A, Kalna G, Karim SA, Au AY, Scarlett CJ, Chang DK, Pajak MZ, Oien KA, McKay CJ, Carter CR, Gillen G, Champion S, Pimlott SL, Anderson KI, Evans TR, Grimmond SM, Biankin AV, Sansom OJ; Australian Pancreatic Cancer Genome Initiative (APGI), Morton JP.

Targeting mTOR dependency in pancreatic cancer Gut. 2014 Sep;63(9):1481-9

Luey N, Toon C, Sioson L, Clarkson A, Watson N, Carmen Cussigh, Andrew Kedziora, Pincott S, Pillinger S, Evans J, Percy J, Engel A,  Schnitzler M,  Gill AJ A further investigation of combined mismatch repair and BRAFV600E mutation specific immunohistochemistry as a predictor of overall survival in colorectal carcinoma PlosOne 2014 Aug 25;9(8):e106105

Kumarasinghe MP, Brown I, Raftopoulos S, Bourke MJ, Charlton A, de Boer B, Eckstein R, Epari K, Gill AJ, Lam AK, Price T, Streutker C, Lauwers GY Standardized reporting protocol for endoscopic resection for Barrett oesophagus associated neoplasia: Expert consensus recommendations Pathology 2014 46(6):473-480

Houang M, Sioson L, Clarkson A, Watson N, Farzin M, Toon CW, Raut A, O’Toole SA, Cooper WA, Pavlakis N, Mead S, Chou A, Gill AJ EGFR mutation specific immunohistochemistry is a useful adjunct which helps to identify false negative mutation testing in lung Pathology 2014  46(6): 501-508

Tan MH, Yee GY, Jorgenson JO, Kuzinkovas V, Talbot ML, Loi KW, Viswanathan S, Gill AJ, A histological evaluation of the laparoscopic adjustable gastric band capsule by tissue sampling during sleeve gastrectomy performed at different timepoints following band removal. Surgery for Obesity and Related Diseases 2014; 10:620–625

Norlén O, Popadich A, Kruijff S, Gill AJ, Sarkis LM, Delbridge L, Sywak M, Sidhu S Bethesda III thyroid nodules: The role of Ultrasound in clinical decision-making Annals of Surgical Oncology 2014; 21(11):3528-33

Guo J, Tretiakova MS, Toxel ML, Osunokoya AO, Fadara O, Sangoi AR, Shen S, Lopez-Beltran A, Mehra R, Heider A, Higgens JP, Harik LR, Leroy X, Gill AJ, Trpkov K, Campbell S, Przybycin C, Magi-Galluzzi C, McKenney JK Tuberous Sclerosis-associated Renal Cell Carcinoma: A Clinicopathologic Study of 57 Separate Carcinomas in 18 Patients Am J Surg Pathol April 2014; 38:1457–1467

Wong MYW, Saad S, Zhang J, Gross S, Jarolimek W, Shilter H, Chen J, Gill AJ, Pollock C, Wong MG Semicarbazide-sensitive amine oxidase (SSAO) inhibition ameliorates kidney fibrosis in a unilateral ureteral obstruction murine model American Journal of Renal Physiology 2014; 307:908-916

Gill AJ, Hes O, Papathomas T, Sedivcova M, Tan PH, Agaimy A, Andresen PA, Kedziora A, Clarkson A, Toon CW, Sioson L, Watson N, Chou A, Paik J, Clifton-Bligh RJ, Robinson BG, Benn DE, Hills H, Maclean F, Niemeijer ND, Vlatkovic L, Hartmann A, Corssmit EPM, van Leenders GJLH, Pryzbycin C, McKenney JK, Magi-Galluzzi C, Yilmaz A, Yu D, Nicoll KD, Yong JL, Sibony M, Yakirevich E, Fleming S, Chow CW, Miettinen M, Michal M, Trpkov Succinate dehydrogenase (SDH) deficient renal carcinoma – a morphologically distinct entity: A clinicopathologic series of 36 tumors from 27 patients American Journal of Surgical Pathology 2014; 38:1588–1602

Sarkis L.M, Olov Norlen, Aniss A, Watson N, Delbridge LW, Sidhu SB, Sywak MS, Gill AJ  The Australian experience with the Bethesda classification system for Thyroid Fine Needle Aspiration Biopsies Pathology 2014;46(7):592-595.

Humphris JL, Johns AL, Simpson SH, Cowley MJ, Pajic M, Chang DK, Nagrial AM, Chin VT, Chantrill LA, Pinese M, Mead RS, Gill AJ, Kench JG, Musgrove EA, Australian Pancreatic Genome Initiative, Tucker K, Spigelman AD, Waddell N, Grimmond SM, Biankin AV Clinical and Pathological Features of Familial Pancreatic Cancer  2014;120(23):3669-75

​

​

​

​

Gill AJ Of mice and men. .. and models of metastatic colorectal carcinoma Colorectal Dis. 2013 2013 15:805-6

Gundara JS, Gill AJ, Neale M, Collins PJ, Hugh TJ, Samra JS Inferior vena cava epithelioid haemangioendothelioma Journal of Vascular: Venous and Lymphatic Disorders Surgery 2013 1:1 75-77

Hasovits C, Pavlakis N, Howell V, Gill AJ, Clark S Resistance to EGFR targeted antibodies - expansion of clones present from the start of treatment. The more things change, the more they stay the same Transl Gastrointest Cancer 2013;2(1). DOI:10.3978/j.issn.2224-4778.2012.10.04

Grieve SM, Lonborg J, Mazhar J, Tan TC, Ho E, Liu C-C, Lay W, Gill AJ, Kuchel P, Bhindi R, Figtree GA Cardiac magnetic resonance imaging of rapid VCAM-1 upregulation in myocardial ischemia-reperfusion injury European Journal of Biophysics 2013 42(1):61-70

Soon PSH, Kim E, Pon, CK, Gill AJ, Moore K, Spillane AJ, Benn DE, Baxter RC Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells Endocrine Related Cancer 2013 20(1):1-12

Dwight T, Benn DE, Clarkson A, Vilain R, Lipton L, Robinson BG, Clifton-Bligh RJ, Gill AJ Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase deficient gastrointestinal stromal tumors American Journal of Surgical Pathology 2013; 37(2):226–233

Lønborg J, Ward M, Gill A, Grieve SM, Figtree GA Utility of cardiac magnetic resonance in assessing right-sided heart failure in sarcoidosis. BMC Med Imaging. 2013 13(1):2.

Clifton-Bligh RJ,  Duncan E, Ewen I, Darnell D, Clarkson A, Wong TW, Walsh J, Gill AJ, Peterre, Hicks R Hofman M Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT Journal of Clinical Endocrinology and Metabolism 2013 Feb;98(2):687-94

Chang DK, Jamieson NB, Johns AL, Scarlett CJ, Pajic M, Chou A, Pinese M, Humphris JL, Jones MD, Toon C, Nagrial AM, Chantrill LA, Chin VT, Pinho AV, Rooman I, Cowley MJ, Wu J, Mead RS, Colvin EK, Samra JS, Bassi C, Falconi M, Lawlor RT, Crippa S, Sperandio N, Bersani S, Dickson EJ, Mohamen MAA, Oien KA, Foulis AK, Musgrove EA, Sutherland RL, Kench JG, Carter CR, Gill AJ, Scarpa A, Mckay CJ, Biankin AV Histomolecular Phenotypes and Outcome in Adenocarcinoma of the Ampulla of Vater Journal of Clinical Oncology 2013; 31:1348-1356.

Mazhar J, Lawley C,  Gill AJ, Grieve SM, Figtree GA Visualizing pericardial inflammation as the cause of acute chest pain in a patient with a congenital pericardial cyst: the incremental diagnostic value of cardiac magnetic resonance European Heart Journal 2013 May;34(19):1413

McCormack A, Kaplan W, Gill AJ,  Little N, Cook R, Robinson BG, Clifton-Bligh RJ  MGMT Expression and Pituitary Tumours: Relationship to Tumour Biology Pituitary  2013 Jun;16(2):208-19

Gundara JS, Gill AJ, Hugh TJ, Samra JS Redefining the apical lymph node at right hemicolectomy European Journal of Surgical Oncology 2013 Jun;39(6):662-5

Dwight T, Mann K, Benn D, Robinson BG, McKelvie P, Gill AJ, Winship I, Clifton-Bligh RJ Familial SDHA mutation associated with pituitary adenoma and pheochromocytoma/paraganglioma Journal of Clinical Endocrinology and Metabolism 2013 Jun;98(6):E1103-E1108

Wang LY, Versnick MA, Gill AJ, Lee JC, Sidhu SB, Sywak MS, Delbridge LW Level VII is an Important Component of Central Neck Dissection for Papillary Thyroid Cancer Annals of Surgical Oncology 2013 Jul;20(7):2261-5

Cooper WA, Yu B, Yip PY, Ng CC, Lum T, Farzin M, Trent RJ, Mercorella B, Clarkson A, Kohonen-Corish MRJ, Horvath LG, Kench JG, McCaughan B, Gill AJ,* O’Toole SA* (*equal senior authors) EGFR Mutant Specific Immunohistochemistry has High Specificity and Sensitivity for Detecting Targeted Activating EGFR Mutations in Lung Adenocarcinoma Journal of Clinical Pathology 2013 66:744-8

Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SAJR, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Børresen-Dale A-L, Boyault A, Burkhardt B, Butler AP, Caldas C, Davies HR, Desmedt C, Eils E, Eyfjörd JE, Foekens JA, Greaves M, Hosoda F, Hutter B, Ilicic T, Imbeaud S, Imielinsk M, Jäger N, Jones DTW, Jones D, Knappskog S, Kool M, Lakhani SR, López-Otín C, Martin S, Munshi NC,Nakamura H, Northcott PA, Pajic M, Papaemmanuil E, Paradiso A, Pearson JV, Puente XS, Raine K, Ramakrishna M, Richardson AL, Richter J, Rosenstiel P, Schlesner M, Schumacher TN, Span PN, Teague JW, Totoki Y, Tutt ANJ, Valdés-Mas R, van Buuren MM, van ’t Veer L,Vincent-Salomon A, Waddell N, Yates LR, Australian Pancreatic Cancer Genome Initiative, ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, ICGC PedBrain, Zucman-Rossi J, Futreal PA, McDermott U, Lichter P, Meyerson M, Grimmond SM, Siebert R, Campo E, Shibata T, Pfister SM, Campbell PJ, Stratton MR Signatures of Mutational Processes in Human Cancer Nature 2013; 500:415–421

Huang CL, Shen S, Ma Q, Chen, J, Gill AJ, Pollock C, Chen, XM Blockade of KCA3.1 Ameliorates Renal Fibrosis Through the TGF-β1/SMAD Pathway in Diabetic Mice Diabetes. 2013 Aug;62(8):2923-34

Chou A, Waddell N, Cowley MJ, Gill AJ, Chang DK, Patch A-M, Nones K, Wu J, Pinese M, Johns AL, Miller DK, Kassahn KS, Nagrial AM, Wasan H, Goldstein D, Toon C, Chin V, Chantrill L, Humphris J, Mead RS, Rooman I, Australian Pancreatic Cancer Genome Initiative, Samra JS, Pajic M, Musgrove EA, Pearson JV, Morey AL, Grimmond SM, Biankin AV Clinical and molecular characterization of HER2 amplified pancreatic cancer Genome Medicine 2013, 5:78

Toon CW, Walsh MJ, Chou A, Dapper D, Clarkson A, Sioson L, Clark S, Mead S, Walters RJ, Clendenning M, Rosty C Young JP, Win AK, Hopper JL, Crook A, von Deimling A, Jenkins MA, Buchanan DB, Gill AJ BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch Syndrome American Journal of Surgical Pathology 2013 37(10): 1592–1602

Westaway DD,Toon CW, Farzin M, Sioson L, Watson N, Brady PW, Marshman D, Mathur M, Gill AJ The International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society grading system has limited prognostic significance in advanced resected pulmonary adenocarcinoma Pathology 2013; 45(6):553-558

Gundara JS, Wang F, Alvarado-Bachmann R, Williams N, Choi J, Gananadha S, Gill AJ, Hugh TJ, Samra JS. The clinical impact of early complete pancreatic head devascularisation during pancreatoduodenectomy American Journal of Surgery 2013; Oct;206(4):518-25

Kassahn KS, Holmes O, Nones K, Patch A-M, Millder DK, Christ AN, Harliwong I, Bruxner TJ, Xu Q, Anderson M, Wood S, Conrad L, Taylor D, Newell F, Song S, Idrisoglu S, Noursel C, Nourbakhsh E, Mannig S, Wanil S, Stepot A, Pajic M, Cowley MJ, Pinese M, Chang DK, Gill AJ, Johns AL, Wu J, Wilson P, Fink L, Biankin AV, Waddell N, Grimmond SM,  Pearson JV Somatic Point Mutation Calling in Low Cellularity Tumors PLoS ONE 2013; 8(11): e74380. doi:10.1371/journal.pone.0074380

Gill AJ, Lipton L, Taylor J, Benn DE, Richardson AL, Frydenberg M, Shapiro J, Clifton-Bligh RJ, Chow CW, Bogwitz M Germline SDHC mutation presenting as recurrent SDH deficient GIST and renal carcinoma  Pathology 2013 45(7):689-691

Lee J, Zhao J, Clifton-Bligh R, Gill AJ, Gundara J, Ip J, Glover A, Sywak M, Delbridge L, Sidhu S MicroRNA-222 and miRNA-146b are Tissue and Circulating Biomarkers of Recurrent Papillary Thyroid Cancer Cancer 2013 119(24):4358-65

Kruijf S, Aniss AM, Chen P, Sidhu SB, Delbridge LW, Robinson B, Clifton-Bligh RJ, Roach P, Gill AJ, Learoyd D, Sywak MS. Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma  Surgery 2013 154(6):1337-1345

Houang M, Clarkson A, Sioson L, Elston MS, Clifton-Bligh RJ, Dray M, Rachere-Vince D, Decouvelaere A-V, Fouchardiere A, Gill AJ Phosphaturic Mesenchymal Tumors Show Positive Staining for Somatostatin Receptor 2A (SSTR2A) Human Pathology 2013 Dec;44(12):2711-8

​

​

​

Hahn MA, Dickson K-A, Jackson S, Clarkson A, Gill AJ, Marsh DJ The tumor suppressor CDC73 interacts with the ring finger proteins RNF20 and RNF40 and is required for the maintenance of histone 2B monoubiquitination Human Molecular Genetics October Hum Mol Genet 2012 21:559-568

Prichard RS, Lee J, Gill AJ, Sywak MS, Sidhu SB, Delbridge l Mucoepidermoid Carcinoma of the Thyroid: A report of three cases and postulated histogenesis Thyroid 2012 22(2):205-9.

Paul RG, Elson MS, Gill AJ, Marsh DJ, Beer I, Wolmarans L, Conaglen JV, Meyer-Rochow GW Hypercalcaemia due to parathyroid carcinoma presenting in the third trimester of pregnancy Australian & New Zealand Journal of Obstetrics & Gynaecology 2012 Apr;52(2):204-7

Pérez-Mancera PA, Rust AG, van der Weyden L, Kristiansen G, Li A, Sarver AL, Silverstein KA, Grützmann R, Aust D, Rümmele P, Knösel T, Herd C, Stemple DL, Kettleborough R, Brosnan JA, Li A, Morgan R, Knight S, Yu J, Stegeman S, Collier LS, ten Hoeve JJ, de Ridder J, Klein AP, Goggins M, Hruban RH, Chang DK, Biankin AV, Grimmond SM; Australian Pancreatic Cancer Genome Initiative, Wessels LF, Wood SA, Iacobuzio-Donahue CA, Pilarsky C, Largaespada DA, Adams DJ, Tuveson DA The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma  Nature 2012 Apr 29;486(7402):266-70.

Gill AJ Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia Pathology 2012 Jun;44(4):285-92.

Mann KM, Ward JM, Yew CC, Kovochich A, Dawson DW, Black MA, Brett BT, Sheetz TE, Dupuy AJ; Australian Pancreatic Cancer Genome Initiative, Chang DK, Biankin AV, Waddell N, Kassahn KS, Grimmond SM, Rust AG, Adams DJ, Jenkins NA, Copeland NG Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):5934-41

Zhang J, Gill AJ, Issacs JD, Atmore B, Johns A, Delbridge LW, Lai R, McMullen TP  The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer Human Pathology 2012 Jul;43(7):1044-50.

Humphris JL, Chang DK, Johns AL, Scarlett CJ, Pajic M, Jones MD, Colvin EK, Nagrial A, Chin VT, Chantrill LA, Samra JS, Gill AJ, Kench JG, Merrett ND, Das A, Musgrove EA, Sutherland RL, Biankin AV The prognostic and predictive value of serum CA19.9 in pancreatic cancer Annals of Oncology 2012 23(7):1713-1722.

Shulte KM, Gill AJ, Barczynski M, Karakas E, Miyauchi A, Knoefel WT, Lombardi CP, Talata N, Diaz-Cano S, Grant CS Classification of Parathyroid Carcinoma Annals of Surgical Oncology 2012 Aug;19(8):2620-8.

Chou A, Chen J, Clarkson A, Samra JS, Clifton-Bligh RJ, Hugh TJ, Gill AJ Succinate Dehydrogenase Deficient GISTs Are Characterized By IGF1R Overexpression Modern Pathology 2012 25:1307–1313

Tactacan CM, Chang DK, Cowly MJ, Humphrey ES, Wu J, Gill AJ, Chou A, Nones K, Grimmond SM, Sutherland RL, Biankin AV, Daily RJ RON is not a prognostic marker for resectable pancreatic cancer BMC Cancer July 2012 Sep 7;12(1):395

Gifford AJ, Colebatch AJ, Litkouhi S, Hersch F, Warzecha W, Snook K, Sywak M, Gill AJ Remote frozen section examination of breast sentinel lymph nodes by telepathology ANZ Journal of Surgery 2012 82:803-8

Song, S., Nones, K., Miller, D., Harliwong, I., Kassahn, K., Pinese, M., Pajic, M., Gill, AJ, Johns, A., Anderson, M., Holmes, O., Leonard, C., Taylor, D., Wood, S., Xu, Q., Newell, F., Cowley, M., Wu, J., Wilson, P., Fink, L., Biankin, A., Waddell, N., Grimmond, S., Pearson, J. qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles PLoS One. 2012;7(9):e45835. doi: 10.1371/journal.pone.0045835

Bullock M, O’Neill C, Chou A, Clarkson A, Dodds T, Toon C, Sywak M, Sidhu SB, Delbridge LW, Robinson BG, Learoyd DL, Capper D, von Deimling A,Clifton-Bligh RJ, Gill AJ Utilisation of a Monoclonal Antibody for BRAFV600E Detection in Papillary Thyroid Carcinoma Endocrine Related Cancer 2012 19(6):779-784

Wang F, Aranagam R, Gill AJ, Puttaswamy V, Neale M, Gananadhal S, Hugh TJ, Samra JS Grafts for mesenterico-portal vein resections can be avoided during pancreatoduodenectomy Journal of the American College of Surgeons 2012; 215(4):569-79

Biankin AV, Waddell N, Kassahn KS, Gingrass M-C, Muthuswamy LB, Johns AL, Miller DK, Wilson PJ, Patch A-M, Wu J, Chang DK, Cowley Mj, Gardiner BB, Song S, Harliwong I, Idrisoglu S, Nourse C, Nourbakhsh E, Manning S, Wani S, Gongora M, Pajic M, Scarlett CJ, Gill AJ, Pinho AV, Rooman I, Anderson M, Holmes O, Leonard C, Taylor D, Wood S, Xu C, Nones K, Fink L, Christ A, Bruxner T, Cloonan N, Kolle G, Newell F, Pinese M, Mead RS, Humphris JL, Kaplan W, Jones MD, Colvin EK, Nagrial AM, Humphrey ES, Chou A, Chin VT, Chantrill LA, Samra JS, Kench JG, Lovell JA, Dayley RJ, Merrett ND, Toon C, Epari K, Nguyen NQ, Barbour A, Zeps N, Australian Pancreatic Cancer Genome Initiative, Kakka N, Zhao F, Wu YQ, Wang M, Muzny DM, Fisher WE, Brunicardi FC, Hodges SE, Reid JG, Drummonds J, Chang K, Han Y, Lewis LL, Dinh H, Buhay CJ, Beck T, Timms L, Sam M, Begley K, Brown A, Pai D, Panchal A, Buchner N, De Borja R, Denroche RE, Yung CK, Serra S, Onetto N, Mukhupadhyay D, Tsa M-S, Shaw PA, Petersen GM, Gallinger S, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Schulick RD, Wolfgang CL, Morgans RA, Lawlor RT, Beghelli S, Corbo V, Scardoni M, Bassi C, Tempero MA, Mann KM, Jenkins NA, Perez-Mancera PA, Adams DJ, Largaespad DA, Wessel LFA, Rust AG, Stein LD, Tuveson DA, Copeland NG, Musgrove EA, Scarpa A, Eshleman JR, Hudson TJ, Sutherland RL, Pearson JV, Wheeler DA, McPherson JD, Gibbs RA, Grimmond S Genomic Analysis Reveals Aberrations in Chromatin Modification and Axon Guidance Pathway Genes in Pancreatic Cancer Nature 2012  491:399-405

Xue A, Chang JW, Chung L, Samra J, Hugh T, Gill AJ, Butturini G, Baxter RC, Smith RC Serum Apolipoprotein C-II is Prognostic for Survival after Pancreatic Resection for Adenocarcinoma British Journal of Cancer 2012; 107(11):1883-91

Lee JC, Zhao JT, Clifton-Bligh RJ, Gill AJ, Gundara JS, Ip J, Sywak MS, Delbridge LW, Robinson BG, Sidhu SB. Papillary Thyroid Carcinoma in Pregnancy: A Variant of the Disease? Annals of Surgical Oncology. 2012 Dec;19(13):4210-6

​

​

​

​

Gill AJ, Clarkson A, Hall G Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma: authors' reply. Pathology. 2011 Jan;43(1):85-6.

Abraham DT, Low T-H, Messina M, Jackson N, Gill AJ, Chou A, Delbridge L, Learoyd D, Robinson BG, Sidhu S, Sywak M   Medullary thyroid carcinoma: Long term outcomes of surgical treatment Annals of Surgical Oncology 2011; 18:219-25

O'Neill CJ, Chan C, Symons J, Learoyd DL, Sidhu SB, Delbridge LW, Gill A, Sywak MS Parathyroid Carcinoma Encountered After Minimally Invasive Focused Parathyroidectomy may not Require Further Radical Surgery. World J Surgery 2011; 35:147-53

Paech DC, Weston AR, Pavlakis N, Gill AJ, Rajan N, Barraclough H, Fitzgerald B, van Kooten M A systematic review of the inter-observer variability for histology in the differentiation between squamous and nonsquamous non-small cell lung cancer Journal of Thoracic Oncology 2011 6:55-63

Nguyen NQ, Johns AL, Gill AJ, Ring N, Chang D, Clarkson A, Merrett ND, Kench JG, Colvin E, Scarlett C, Biankin AV Clinical and immunohistochemical features of 34 solid pseudopapillary tumours of the pancreas Journal of Gastroenterology and Hepatology 2011; 26:267-274

Gill AJ, Pachter NS, Clarkson A, Tucker KM, Winship I, Benn DE, Robinson BG, Clifton-Bligh R Renal Tumors and Hereditary Pheochromoytoma-Paraganglioma Syndrome New England Journal of Medicine 2011 364; 9:885-886

Zhang JD, Gill AJ, Atmore B, Johns AL, Delbridge L,  Lai R, McMullen T Upregulation of the signal transducers and activators of transcription 3 (STAT3) pathway in lymphatic metastases of papillary thyroid cancer International Journal of Clinical and Experimental Pathology 2011 4(4):356-62.

Abraham D, Jackson NE, Gundara JS, Zhao J, Gill AJ, Delbridge L, Robinson B, Sidhu S MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis and potential therapeutic targets Clinical Cancer Research 2011 Jul 15;17(14):4772-81

Gill AJ, Chou A, Vilain RE, Clifton-Bligh RJ “Pediatric type” Gastrointestinal stromal tumors are SDHB negative (“type 2”) GISTs American Journal of Surgical Pathology 2011 35(8):1245–1247

Colebatch A, Clarkson A, Gill AJ  Benign mesothelial cells as confounders when cytokeratin immunohistochemistry is used in sentinel lymph nodes Human Pathology 2011 42 (8):1210-1211

Samra JS, Bachmann RA, Choi J, Gill AJ, Neale M, Puttaswamy V, Bell C, Norton I, Cho S, Blome S, Maher R, Gananadha S, Hugh TJ One hundred and seventy-eight consecutive pancreatoduodenectomies without mortality: role of the multidisciplinary approach. Hepatobiliary and Pancreatic Disease International 2011 Aug;10(4):415-21.

Brown S, O’Neill C, Sulibruk J, Sidhu S, Sywak M, Gill AJ, Robinson B, Delbridge L Parathyroid carcinoma: Increasing incidence and changing presentation Australian and New Zealand Journal of Surgery 2011 81:528-532

Galougahi KK, Harden M, Maher R, Gill A, Bhindi R, Grieve SM, Brady P, Figtree GA. Incremental diagnostic value of magnetic resonance imaging in the characterization of a cardiac mass. J Am Coll Cardiol. 2011 Aug 30;58(10):e19.

Lim S, Elston MS, Gill AJ, Marsh DJ, Conaglen JV Metastatic parathyroid carcinoma initially misdiagnosed as parathyroid adenoma – the role of parafibromin in increasing diagnostic accuracy  Internal Medicine Journal 2011 41(9):695-9

Sandanayake NS, Sinclair J, Andreola F, Chapman MH, Xue A, Clarkson A, Gill AJ, Webster GJ, Norton ID, Smith RC, Timms JF, Pereira SP A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures British Journal of Cancer 2011 105(9):1370-8

Gundara JS, Alvarado-Bachman R, Williams N, Gananadha S, Gill AJ, Hugh TJ, Samra JS Multivisceral resection of pancreatic neuroendocrine tumours: a report of two cases World Journal of Surgical Oncology 2011, 9:93

Gill AJ, Pachter NS, Chou A, Young B, Clarkson A, Tucker KM, Winship IM, Earls P, Benn DE, Robinson BG, Fleming S, Clifton-Bligh RH The renal tumors associated with germline SDHB mutation show distinctive morphology American Journal of Surgical Pathology 2011 35(10):1578-1585

Paik JY, Hall G, Clarkson A, Lee L, Toon C, Colebatch A, Chou A, Gill AJ Immunohistochemistry for Merkel cell polyomavirus is highly specific but not sensitive for the diagnosis of Merkel cell carcinoma in the Australian population Human Pathology 2011 42(10): 1385-1390

​

​

​

Hahn M, Howell V, Gill AJ, Clarkson A, Robinson B, Delbridge L, Gimm O, Teh B, Marsh D CDC73/HRPT2 CpG Island hypermethylaiton and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors Endocrine Related Cancer 2010 (17): 273 - 282

Gill AJ, Chou A, Vilain R, Clarkson A, Lui M, Jin R, Tobias V, Samra J, Goldstein D, Smith C, Sioson L, Parker N, Smith RC, Sywak M, Sidhu SB, Ma Wyatt J, Robinson BG, Benn DE, Clifton-Bligh RJ Immunohistochemistry for SDHB divides Gastrointestinal Stromal Tumors (GISTs) into two distinct types American Journal of Surgical Pathology 2010 34:636-44

Gill AJ, Benn DE, Chou A, Clarkson A, Muljono A, Meyer-Rochow G, Richardson A-L, Sidhu SB, Robinson BG, Clifton-Bligh RJ Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC and SDHD in paraganglioma-phaeochromocytoma syndromes Human Pathology 2010 41:805-814

Grieve SM, Bhindi R, Seow J, Doyle A, Turner AJ, Tomka J, Lay W, Gill AJ, Hunyor ST, Figtree GA Microvascular Obstruction by Intracoronary Delivery of Mesenchymal Stem Cells and Quantification of Resulting Myocardial Infarction by Cardiac Magnetic Resonance  Circ Heart Fail. 2010;3:e5-e6, doi:10.1161/CIRCHEARTFAILURE.109.931360

Aslan A, Gill AJ, Roach PJ, Allen BJ, Smith RC Pre-operative body composition is influenced by the stage of operable pancreatic adenocarcinoma but does not predict survival after Whipple’s Procedure IHBPA Journal HPB 2010 12:325-333

Hall G, Clarkson A, Shi A, Langford E, Leung H, Eckstein RP, Gill AJ Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma Pathology 2010 42:409–413

Meyer-Rochow GY, Jackson NE, Conaglen JV, Whittle DE, Kurmimalniyaan M, Chen H, Wesifin G, Sandgren J, Stalberg P, Khanafshar E, Shibru D, Duh QY, Clark OH, Kebeler E, Gill AJ, Clifton-Bligh R, Robinson BG, Benn DC, Sidhu SB MicroRNA profiling of benign and malignant pheochromocytoma identifies novel diagnostic and therapeutic targets Endocrine Related Cancer 2010: 835 -846     

Pang T, Ihre-Lundgren C, Gill AJ, McMullen T, Sywak M, Sidhu S, Delbridge L Correlation beween indeterminate aspiration cytology and final histopathology of thyroid neoplasms Surgery 2010;148:532-7

Stevenson WS, Hyland CD, Zhang J-G, Morgan PO, Wilson TA, Gill AJ, Hilton AA, Viney EM, Bahlo M, Masters SL, Hennebrey S, Richardson SJ, Nicola NA, Metcalf D, Hilton DJ, Roberts AW, Alexander WS Deficiency of 5-hydroxyisourate hydrolase causes hepatomegaly and hepatocellular carcinoma in mice Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16625-30

Losa M, Mazza E, Terreni MR, McCormack A, Gill AJ, Motta M, Cangi MG, Talarico A, Mortini P, Reni M  Salvage therapy with Temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases  Eur J Endocrinol. 2010 163:843-851

O'Neill CJ, Bullock M, Chou A, Sidhu SB, Delbridge LW, Robinson BG, Gill AJ, Learoyd DL, Clifton-Bligh R, Sywak MS BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer Surgery. 2010 148(6):1139-1146.

​

​

​

Gill AJ, Johns AL, Eckstein R, Samra JS, Kaufman A, Chang DK, Merrett ND, Cosman PH, Smith RC, Biankin AV, Kench JG Synoptic Reporting Improves Histopathological Assessment of Pancreatic Resection Specimens Pathology 2009  41:161-167

Howell VM, Gill AJ, Clarkson A,, Delbridge LW,  Dunne R, Nelson AE, Robinson BG, Gimm O, Teh BT, Marsh DJ Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma Journal of Clinical Endocrinology and Metabolism 2009 94(2):434-441

McMullen T, Lundgren C, Gill AJ,  Shun A, Sywak M, Sidhu S, Delbridge L Hyperparathyroidism following irradiation for childhood malignancy International Journal of Radiation Oncology, Biology, Physics 2009 March 73(4):1164-8.

Meyer-Rochow GY, McMullen TP, Gill AJ, Sywak MS, Robinson BG Intra-abdominal Insular Thyroid Carcinoma Metastasis Thyroid 2009 May;19(5):527-30

Chang DK, Johns AL, Merrett ND, Gill AJ, Colvin EK, Scarlett CJ, Nguyen NQ, Leong RWL, Cosman PH, Kelly MI, Sutherland RL, Henshall SM, Kench JG, Biankin AV  Margin Clearance and Outcome in Resected Pancreatic Cancer Journal of Clinical Oncology 2009 June 27(17):2855-62

Soon PSH, Gill AJ, Benn DE, Clarkson A, Robinson BG, McDonald KL, Sidhu SB

Microarray gene expression and immunohistochemistry analyses of  adrenocortical tumours identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas Endocrine Related Cancer 2009 June16(2):573-583.

Elston MS, Gill AJ, Conaglen JV, Clarkson A, Cook RJ, Little NS, Robinson BG, Clifron-Bligh RJ, McDonald KL Nuclear accumulation of E-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomas Journal of Clinical Endocrinology and Metabolism 2009 April 94(4):1436-42

McCormack A, Mcdonald KL, Gill AJ,  Clark SJ, Burt MG, Campbell KA, Braund WJ,  Little NS, Cook RJ, Grossman AB, Robinson BG, Clifton-Bligh RJ Low MGMT expression and response to temozolomide in aggressive pituitary tumours Clinical Endocrinology 2009 71(2):226-233

Tacon LJ, Soon PS, Gill AJ, Chou AS, Clarkson A, Botling J, Stalberg P, Skosgseid B, Robinson BG, Sidhu SB, Clifton-Bligh RH The glucocorticoid receptor is overexpressed in malignant adrenocortical tumors Journal of Clinical Endocrinology and Metabolism 2009 94: 4591-4599

Khasraw M, Gill AJ, Harrington T,  Pavlakis N, Modlin I Management of advanced neuroendocrine tumour with hepatic metastasis Journal of Clinical Gastroenterology  2009 October 43(9):838-847

Soon P, Tacon L, Gill AJ, Bambach C, Sywak MS, Capmbell P, Yeh MW, Wong SG, Clifton-Bligh R, Robinson BG, Sidhu S  MicroRNA microarray analysis of human adrenocortical tumors identifies miR-195 and miR-483-5p as predictors of poor prognosis in adrenocortical cancer Clin Cancer Res 2009;15(24) 7684-7692

​

​

​

​

Gill AJ, Delbridge L Invited commentary: Prevalence and prognostic significance of poor differentiation and tall cell variant in papillary carcinoma in Japan. World Journal of Surgery 2008 32: 1544-1545

​

Soon PSH, Libe R, Benn DE, Gill A, Shaw J, Sywak MS, Groussin L, Bertagna X, Gicquel C, Bertherat J, McDonald KL, Sidhu S, Robinson BG Loss of Heterozygosity of 17p13, with Possible Involvement of ACADVL and ALOX15B, in the Pathogenesis of Adrenocortical Tumors Annals of Surgery 2008 247(1):157-164

Saxby A, Gill A, Samra J Education and Imaging: Hepatobiliary and Pancreatic: Pseudotumor of the Pancreas Journal of Gastroenterology and Hepatology 2008;23(2):340

Grodski S, Gill A, Robinson B, Sidhu S Non functioning parathyroid cancer presenting as a cervical mass Thyroid 2008 18(4):473-4.

Elston MS, Gill AJ, Conaglen JV, Clarkson A, Shaw JM, Law AJ, Cook RJ, Little NS, Clifton-Bligh RJ, Robinson BG, McDonald KL  Wnt pathway inhibitors are strongly down-regulated in pituitary tumors Endocrinology, 2008  149(3):1235-42

Tacon L, Tan CTK, Albarado R, Gill AJ, Sywak M, Fulcher G Drug-Induced thyroiditis and papillary carcinoma in a minocycline-pigmented black thyroid gland Thyroid 2008 18:795-797

Alexander S, Bourke MJ, Williams SJ, Bailey A, Gill A, Kench JG Diagnosis of autoimmune pancreatitis with intraductal biliary biopsy and treatment of stricture with serial placement of multiple biliary stents Gastrointestinal Endoscopy 2008 68: 396-399

Kuo SCL, Gananadha S, Scarlett CJ, Gill AJ, Smith RC Sporadic Pancreatic Polypeptide Secreting Tumours (PPomas) of the Pancreas World Journal of Surgery 2008 32: 1815-1832

Weir C, Morel-Kopp M-C, Gill AJ, Tinworth K, Ladd L, Hunyor SN, Ward C Mesenchymal stem cells: isolation, characterisation and in vivo fluorescent dye tracking Heart, Lung and Circulation 2008 17:395-403

Lu M, Forsberg L, Hoog A, Juhlin C, Vukojevic V, Larsson C, Conigrave A, Delbridge L, Gill A, Bark C, Farnebo L-O, Branstrom R Hetereogeneous Expression of SNARE proteins, SNAP-23 SNAP-25, Syntaxin 1 and VAMP in human parathyroid tissue Molecular and Cellular Endocrinology 2008 287:72-80

Au A, Mcdonald K, Gill AJ, Sywak M, Diamond T, Conigrave A, Clifton-Bligh R PTH Mutation Associated with Primary Hyperparathyroidism and Undetectable intact PTH New England Journal of Medicine 2008 359:1184-1186

Grodski S, Brown T, Sidhu S, Gill AJ, Robinson B, Learoyd D, Sywak M, Reeve T, Delbridge L Increasing incidence of thyroid cancer is due to increased pathologic detection Surgery 2008 144(6):1038-1043

​

​

​

Smith R, Xue A, Gill A, Scareltt C, Saxby A, Clarkson A, Hugh T  High expression of Plasminogen Activator Inhibitor-2 (PAI-2) is a predictor of improved survival in patients with pancreatic adenocarcinoma  World Journal of Surgery 2007 Mar;31(3):493-502

​

Meyer-Rochow GY, Alvarado R, Sywak MS, Sidhy SB, Delbridge LW, Gill AJ Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma British Journal of Surgery 2007 94(8):1044

Moradi P, Barakate M, Gill A, Farrow G Intussusception of the vermiform appendix due to endometriosis presenting as acute appendicitis Australian and New Zealand Journal of Surg 2007 77(9):758-760

Marsh DJ, Hahn MA, Howell VM, Gill AJ Molecular diagnosis of primary hyperparathyroidism in familial cancer syndromes  Expert Opinion in Medical Diagnostics November 2007, Vol 1, No.3

​

​

​

Gill AJ Cannabis, pneumothorax and bullous lung disease  Journal of the Royal Society of Medicine 2006 99(4):169-170

Stewart I, Roddie C, Gill A, Clarkson A, Mirams M, Coyle L, Ward C, Clifton-Bligh P, Robinson BG, Mason RS, Clifton-Bligh RJ Elevated serum FGF-23 in plasma cell dyscrasias   Bone 2006, 39(2): 369-376

Gill AJ, Clarkson A, Gimm O, Keil J, Dralle H, Howell VM, Marsh DJ. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and Hyperparathyroidsim-Jaw Tumor (HPT-JT) syndrome related adenomas from sporadic parathyroid adenomas and hyperplasias   American Journal of Surgical Pathology 2006 30(9):1140-1149

Samra JS, Gananadha S, Gill A, Smith RC Hugh TJ Modified extended pancreaticoduodenectomy: En block resection of the peripancreatic retroperitoneal tissue and the head of pancreas Australian and New Zealand Journal of Surgery 2006, 76(11): 1017-1020

​

​

​

Nielsen A, Scarlett CJ, Samra JS, Gill A, Li Y, Allen BJ, Smith RC  Significant overexpression of urokinase plasminogen activator (uPA) in pancreatic adenocarcinoma using real-time quantative RT-PCR.  Journal of Gastroenterology and Hepatology 2005; 20 256-263

Gill A Regular smokers of cannabis show relatively characteristic histological features which predispose to pneumothorax American Journal of Surgical Pathology 2005; 29 (7) 680-682

Saxby AJ, Nielsen A, Scarlet CJ, Clarkson A, Morey A, Gill  A, Smith RC  Assessment of  Her-2 status in pancreatic adenocarcinoma: Correlation of immunohistochemistry, Q-RT-PCR and FISH with aneuploidy and survival  American Journal of Surgical Pathology 2005 29(9):1125-1134

​

​

​

Gill AJ, Mathur MN, Tattersall SF   Talc Dissemination is not necessary for the talc pleurodesis syndrome. American Journal of Respiratory and Critical Care Medicine 2004; 169:1074-1075

Pendle S, Weeks K, Priest M, Gill A, Hudson B, Kotsiou G, Pritchard R   Phaeohyphomycotic soft tissue infections caused by the coelomycetous fungus Microsphaeopsis arundinis  Journal of Clinical Microbiology 2004; 42 (11) 5315-5319

Allan R, Gill A, Spittaler P Recurrent Medulloblastoma – violation of Collin’s law by 14 years  Journal of Clinical Neuroscience 2004; 11(7):756-757

​

​

​

​

Cheung L, Messina M, Gill AJ, Clarkson A, Learoyd D, Delbridge L, Wentworth J, Philips J, Clifton-Bligh R, Robinson BG   Detection of the PAX8-PPARγ fusion oncogene in both follicular thyroid carcinomas and adenomas.  Journal of Clinical Endocrinology and Metabolism 2003; 88 (1): 354-357

Nelson AE, Clifton-Bligh R, Mirams M, Gill AJ, Au A, Clarkson A, Jueppner H, Ruff S, Stalley P, Scolyer R, Robinson BG.   Clinical Case Seminar - FGF23: a new clinical marker for oncogenic osteomalacia. Journal of Clinical Endocrinology and Metabolism 2003; 88 (9): 4088-4094

2020